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A B S T R A C T   
Background: WHO has published several volumes of Global Air Quality Guidelines to provide guidance on the 
health risks associated with exposure to outdoor air pollution. As new scientific evidence is generated, air quality 
guidelines need to be periodically revised and, where necessary, updated. 
Objectives: The aims of the study were 1) to summarise the available evidence on the effect of long-term ex-
posure to ozone (O3) and nitrogen dioxide (NO2) on mortality; 2) and to assess concentration response functions 
(CRF), their shape and the minimum level of exposures measured in studies to support WHO’s update of the 
global air quality guidelines. 
Data sources: We conducted a systematic literature search of the Medline, Embase and Web of Science databases 
following a protocol proposed by WHO and applied Preferred Reporting Items for Systematic Review and Meta- 
Analyses (PRISMA) guidelines for reporting our results. 
Study eligibility criteria: Cohort studies in human populations (including sub-groups at risk) exposed to long- 
term concentrations of NO2 and O3. Outcomes assessed were all-cause, respiratory, Chronic Obstructive 
Pulmonary Disease (COPD) and Acute Lower Respiratory Infection (ALRI) mortality. 
Study appraisal and synthesis methods: Studies included in the meta-analyses were assessed using a new Risk 
of Bias instrument developed by a group of experts convened by WHO. Study results are presented in forest plots 
and quantitative meta-analyses were conducted using random effects models. The certainty of evidence was 
assessed using a newly developed adaptation of GRADE. 
Results: The review identified 2068 studies of which 95 were subject to full-text review with 45 meeting the 
inclusion criteria. An update in September 2018 identified 159 studies with 1 meeting the inclusion criteria. Of 
the 46 included studies, 41 reported results for NO2 and 20 for O3. The majority of studies were from the USA 
and Europe with the remainder from Canada, China and Japan. Forty-two studies reported results for all-cause 
mortality and 22 for respiratory mortality. 
Associations for NO2 and mortality were positive; random-effects summary relative risks (RR) were 1.02 (95% 
CI: 1.01, 1.04), 1.03 (1.00, 1.05), 1.03 (1.01, 1.04) and 1.06 (1.02, 1.10) per 10 μg/m3 for all-cause (24 cohorts), 
respiratory (15 cohorts), COPD (9 cohorts) and ALRI (5 cohorts) mortality respectively. The review identified 
high levels of heterogeneity for all causes of death except COPD. A small number of studies investigated the 
shape of the concentration–response relationship and generally found little evidence to reject the assumption of 
linearity across the concentration range. 
Studies of O3 using annual metrics showed the associations with all-cause and respiratory mortality were 0.97 
(0.93, 1.02) and 0.99 (0.89, 1.11) per 10 μg/m3 respectively. For studies using peak O3 metrics, the association 
with all-cause mortality was 1.01 (1.00, 1.02) and for respiratory mortality 1.02 (0.99, 1.05), each per 10 μg/m3. 
The review identified high levels of heterogeneity. Few studies investigated the shape of the con-
centration–response relationship. 
Certainty in the associations (adapted GRADE) with mortality was rated low to moderate for each exposure- 
outcome pair, except for NO2 and COPD mortality which was rated high. 
Limitations: The substantial heterogeneity for most outcomes in the review requires explanation. The evidence 
base is limited in terms of the geographical spread of the study populations and, for some outcomes, the small 
number of independent cohorts for meta-analysis precludes meaningful meta-regression to explore causes of 
heterogeneity. Relatively few studies assessed specifically the shape of the CRF or multi-pollutant models. 
Conclusions: The short-comings in the existing literature base makes determining the precise nature (magnitude 
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and linearity) of the associations challenging. Certainty of evidence assessments were moderate or low for both 
NO2 and O3 for all causes of mortality except for NO2 and COPD mortality where the certainty of the evidence 
was judged as high.   
1. Introduction 
Outdoor air pollution has been a global concern for decades, par-
tially due to economic growth and urbanisation. Air pollution has been 
recognised as a major environmental hazard to human health and a 
cause of mortality and morbidity (Burnett et al., 2018; World Health 
Organization, 2012). Nitrogen dioxide (NO2) is a toxic gas with both 
outdoor (e.g. traffic) and indoor (e.g. gas cooking) sources. In outdoor 
urban environments, NO2 is derived primarily from the oxidation of 
nitric oxide (NO) a primary traffic pollutant. Ozone (O3) is a highly 
reactive oxidative gas formed by chemical reactions in the atmosphere 
involving oxides of nitrogen, volatile organic compounds and driven by 
solar radiation. In urban areas with high traffic density, nitrogen oxides 
(NO and NO2) are commonly high and often negatively correlated with 
O3 during daylight hours. Evidence suggested that NO2 and O3 both 
detrimentally affect people’s health, including respiratory function, 
hospital admission, and premature death (Nuvolone et al., 2018; 
Strickland et al., 2010; Malig et al., 2016; Urman et al., 2014). 
WHO has previously published Global Air Quality Guidelines 
(AQGs) to provide guidance to the public and to policy and other de-
cision makers on the health risks associated with exposure to outdoor 
air pollution (WHO, 2000; WHO, 2005). As new scientific evidence is 
generated, air quality guidelines need to be periodically revised and, 
where necessary, updated. The update of the WHO AQGs is a global 
project coordinated by the WHO Regional Office for Europe’s European 
Centre for Environment and Health (ECEH) in Bonn (Germany), in-
cluding participation from all WHO Regions and WHO headquarters. In 
support of this update, systematic reviews of both short- and long-term 
studies on air pollutants and mortality and morbidity are necessary. 
This review focuses upon long-term concentrations of NO2 and O3 
and all-cause and respiratory mortality studied in epidemiological co-
hort studies. Previous reviews of NO2 (Atkinson et al., 2018; Faustini 
et al., 2014; Hoek et al., 2013; EPA, 2016; WHO, 2013) and O3 (WHO, 
2013; Atkinson et al., 2016; EPA US, 2013) have been undertaken. 
However, in order to ensure guideline revisions are informed by the 
latest evidence, a new review was undertaken with formal evaluation of 
Risk of Bias (RoB) and certainty of evidence (Grading of Re-
commendations Assessment, Development and Evaluation (GRADE)). 
For the reviews new adaptations of the RoB and GRADE assessments 
were developed. 
The aims of the study were 1) to conduct an extensive systematic 
review and meta-analysis on associations between long-term con-
centrations of NO2 and O3 on mortality; and 2) to assess concentration 
response functions, their shape and the minimum level of exposures 
measured in studies. The following framework (Appendix Table B1) 
was used to select the critical health outcome(s) for each pollutant: 1) 
Evidence on causality for a health outcome based upon the latest de-
termination (causal or likely causal) from US EPA, IARC, Health Canada 
or other integrated science assessments available; 2) Using the pre-
cautionary principle, additional most severe health outcomes other 
than causal or likely causal (e.g. suggestive causality) were considered 
for inclusion taking into account contribution to burden of disease 
(prevalence of disease, disability weight, etc), policy implications, ex-
pected increase in exposure to a pollutant in the future, etc.; 3) caus-
ality determination superseded severity of a health outcome but, in 
some cases, two (or more) different health outcomes may be system-
atically evaluated for the same pollutant (e.g. one with a definite or 
likely causal link to the pollutant, and another health outcome for 
which the evidence is suggestive but which is very severe or prevalent 
in the population). Severity of disease was informed by considerations 
proposed by the joint European Respiratory Society and American 
Thoracic Society latest policy statement on health effects from air 
pollution (fatality, persistence of effect, susceptible groups, and med-
ical/functional significance including loss of autonomy and reduced 
quality of life) (Thurston et al., 2017). 
This systematic review uses the following Population, Exposure, 
Comparison, Outcome, Study Design (PECOS) statement: in any popu-
lation, including subgroups of susceptible adults and children (P), what 
is the health effect of long-term ambient exposure of NO2 and O3 (E) per 
unit increase in μg/m3 (C) on all cause, respiratory, Chronic Obstructive 
Pulmonary Disease (COPD), and Acute Lower Respiratory Infection 
(ALRI) mortality (O), observed in cohort studies (S)? Additionally, in 
Table 1 
Inclusion and exclusion criteria for each PECOS domain in relation to long-term exposure and health effects to selected air pollutants.     
PECOS Inclusion Exclusion  
Population  • General human population (including sub-groups at risk: children, pregnant women, 
elderly, or patients with particular conditions), of all ages, developed and developing areas, 
both urban and rural. No geographical restrictions.  
• Study population expose to the pollutant of interest via inhalation through ambient air 
predominantly  
• Study population expose to the pollutant of interest in 
occupational settings or indoor exposure exclusively 
Exposure  • Long-term exposure (order of years) to ambient air O3 and NO2 expressed in a 
concentration unit (ppb and μg/m3 respectively).  
• Less than one year of data available 
Comparator  • Exposure to per concentration increased unit of the air pollutant of interest in the same 
population  
• Increment for hazard ratio not given 
Outcome  • Health outcomes selected in relation to long-term exposure include (ICD 10 codes, version 
2016 in brackets): all cause (A00-Z99); respiratory (J00-J99); COPD (J40-47) and ALRI 
(J12-J18, J20-J28) mortality [Note: Studies vary in selection of codes.]  
• Birth outcomes (due to neonatal exposure of pollutant) 
Study  • Human epidemiological studies including:  
o Prospective and retrospective 
cohort studies  
• Published (or accepted for publication i.e. in press) journal articles in any language 
(abstract in English language), conference abstracts and papers, letters, notes, grey 
literature.  
• If suitable articles are identified published in languages not known by the SRT, further 
assistance will be sought after (members of the GDG or external review team from different 
regions, colleagues, researcher networks, etc)  
• Qualitative studies  • Case control studies  • No adjustment for socio-economic status (individual or area)  • Studies where no original data were analysed  • Reviews and methodological papers  • Non-human studies (in vivo, in vitro, other)  • Insufficient information given to standardise hazard ratio and 
precision (standard error or confidence interval) 
SRT: Systematic review team  
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these studies, what is the lowest concentration that produces a mea-
surable increase in risk?” 
2. Methods 
2.1. Protocol 
The protocol for this review was developed by WHO based largely 
on standards set by the Cochrane Collaboration and adapted for ap-
plication to observational studies (Higgins, 2011) and the Preferred 
Reporting Items for Systematic Review and Meta-analysis Protocols 
(PRISMA-P) standards (Moher, 2009; Shamseer et al., 2015). The pro-
tocol is published in the International Prospective Register of Sys-
tematic Reviews (PROSPERO) reference number CRD42018089853. 
2.2. Eligibility criteria 
The included population comprised general human population (in-
cluding sub-groups at risk) of all ages, exposed to long-term (i.e.  >  one 
year) concentrations (order of years) to ambient NO2 and O3 (Table 1). 
As whole populations are exposed to varying levels of air pollution, the 
comparison is between subjects in the same population exposed at 
different concentrations of the pollutant. Outcomes included in the 
review were mortality from all-causes (A00-Z99); respiratory diseases 
(J00-J99); COPD (J40-47) and ALRI (J12-J18, J20-J28). We included 
publication of prospective and retrospective cohort studies, published 
(or accepted for publication) journal articles in any language, con-
ference abstracts and papers, letters, notes, and grey literature. Cohort 
studies were selected for the review as they are used in environmental 
epidemiology to assess associations between long-term (over years) 
concentrations of pollutants and risk of death. 
We excluded 1) studies with exposure of interest in occupational or 
indoor settings exclusively; 2) studies that explored neonatal exposure 
and birth outcomes; 3) studies that had less than one year of data 
available; 4) studies did not report exposure increment for the health 
effect; 5) qualitative studies; 6) case-control studies (not applicable to 
the study of mortality in air pollution epidemiology); 7) studies without 
any adjustment for socio-economic status (either at individual or area 
level); 8) studies had no original data analysed; 9) reviews and meth-
odological papers; 10) non-human studies (e.g. in vivo, in vitro); 11) 
studies with insufficient information to standardise effect size and 
precision (Table 1). 
2.3. Information sources 
To identify articles reporting results of studies matching the PECOS 
questions the bibliographic databases Medline, Embase and Web of 
Science were searched without limitation on date. The search strategy 
included terms related to the study design, pollutant and outcome is 
documented fully in Appendix Table B2. Results of the three searches 
were combined and de-duped. In addition, the reference lists of relevant 
reviews were scanned to identify additional published data matching 
the PECOS question. All references were downloaded into Endnote re-
ference manager software [Endnote X7.8 Thomson Reuters]. 
2.4. Study selection 
Two authors (PH and RWA) independently screened the titles and 
abstracts of the studies returned by the systematic searches. Articles 
that did not meet the prespecified eligibility criteria (Table 1) were 
identified and excluded. 
2.5. Data collection 
Data extraction was conducted independently by PH and RWA and 
compared. Study information collected included citation details (title, 
authors, date of publication); cohort details (name, country, patient/ 
population group, follow up period(s)); subject characteristics (age at 
recruitment, sex, occupation); confounders measured; exposure as-
sessment method (e.g. monitor, land use regression model); mean and 
concentration range of the pollutant (e.g. 5th & 95th percentile or 
minimum/ maximum or 25th/75th percentile values); outcome as-
sessment (e.g. death records, ICD coding); and details of the risk esti-
mates including exposure unit of measurement, metric description (e.g. 
annual mean), period of year of exposure assessment (all-year or 
‘warm/peak season’), and 95% confidence interval (CI) of the risk es-
timates for relevant outcomes; and details on co-pollutant models. 
Where disagreement occurred, it was resolved by discussion. Data 
extracted from the articles were entered into an Excel spreadsheet. In 
the absence of complete descriptions of exposure assessment and out-
comes, effect estimates, or other important information, individual 
authors were contacted and the information requested. 
2.6. Standardisation of risk estimates 
Risk estimates extracted from cohort studies were hazard ratios 
(HR) and 95% CIs in the units reported in the original studies. For the 
purpose of this review HRs were considered to be equivalent to relative 
risks (RR). Where risk estimates were reported in parts per billion 
(ppb), standard factors were used to convert ppb to μg/m3; for NO2 and 
O3 these were 1.88 and 1.96 respectively (Air Information Resource, 
2005). RRs (and 95% CIs) were scaled to 10 μg/m3 increments by 
taking the natural logarithm of the risk estimates (and confidence 
limits) and then standardising to 10 μg/m3 by dividing by the original 
risk increment and multiplying by 10. Standardisation to a common 
metric is required to enable risk estimates to be combined in a meta- 
analysis. 
2.7. Data synthesis 
Some cohorts have been analysed in more than one study (e.g. for 
different follow-up periods, for more sophisticated air pollution models 
etc.) or included in a multi-cohort analysis (e.g. the European Study of 
Cohorts for Air Pollution Effects (ESCAPE) study). We therefore selected 
only one result from each cohort for inclusion in the meta-analysis. The 
selection procedure was based upon the following criteria: the cohort 
using the most recent follow-up period (i.e. more recent studies with 
longer follow-up, represent more recent exposure status, and with im-
proved exposure measurement to aid the global guidelines update), 
results from the full cohort rather than a subset, and if results for a 
cohort were not included in a multi-cohort study. 
Meta-analysis was performed using random-effects (RE) models 
with heterogeneity estimated using restricted maximum likelihood 
(REML) as implemented in the ‘admetan’ command in STATA Vn 15 
(StataCorp, 2017). Forest plots were produced using the ‘admetan’ 
program in STATA. Summary estimates (i.e. RR), 95% CIs, Chi-square 
statistics, tau2, I2 and 80% prediction intervals were reported. Where 
more than 10 studies were available for analysis, potential small study 
bias was assessed using the funnel plot and funnel plot asymmetry using 
Egger’s test (Begg and Berlin, 1989; Egger et al., 1997) as implemented 
in the STATA command ‘metabias’. Meta regression was used to study 
the relationship between study RRs and mean pollutant concentrations 
(‘metareg’ in STATA Vn 15) when 10 or more estimates were available. 
Cohorts investigating O3 and mortality may use annual or ‘peak’ 
season (e.g. April-September) measures of exposure. Meta-analyses for 
O3 were therefore stratified by exposure period. 
2.8. Risk of bias evaluation 
A new RoB tool was developed by a working group convened by 
WHO for the assessment of cohort studies in air pollution epidemiology 
(https://www.euro.who.int/en/health-topics/environment-and- 




guidelines-2020). The tool consisted of six domains: confounding, se-
lection bias, exposure assessment, outcome assessment, missing data 
and selective reporting, each including one to four subdomains. In total, 
13 sub-domains (Morgan et al., 2019) were each rated as low, moderate 
or high risk of bias. If any one sub-domain was rated medium or high 
RoB then the domain was rated similarly. RoB was applied to each 
pollutant-outcome pair for studies included in a meta-analysis. Assess-
ment of RoB for the confounding sub-domain “Were all confounders 
considered adjusted for in the analysis?” was based upon the inclusion 
in the analysis of critical and potential confounders according to the 
outcome. For all-cause mortality critical confounders were: age, sex, 
body mass index (BMI) and an indicator (individual or area) for socio- 
Fig. 1. Flowchart of assessment of studies.  
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economic status (SES). For respiratory outcomes critical confounders 
included age, sex, smoking and SES. Potential critical confounders in-
cluded: year of enrolment, ethnicity, diet, physical activity, marital 
status, and smoking/BMI according to inclusion as critical confounder. 
2.9. Additional analyses 
Pre-specified sub-group analyses were performed where sufficient 
numbers of studies were available for meaningful analysis (i.e. a 
minimum of five studies in each subgroup). Sub-groups were defined 
by: 1) cohorts comprised of patient group versus general population 
cohorts; 2) cohorts able to control for individual measures of BMI, 
smoking and SES; 3) WHO region (Region of the Americas (AMR); 
European Region (EUR); Western Pacific Region (WPR)); and 4) by 
low/high RoB. Sensitivity analyses were conducted excluding high RoB 
studies (where sub-group analysis was not performed). 
2.10. Certainty of evidence assessment 
Certainty of evidence for each pollutant / outcome pair was assessed 
using a modified GRADE adapted following discussions of a working 
group composed of methodologists and GDG members, under the 
oversight of the WHO Secretariat (see Appendix A for WHO guidance in 
detail). We briefly describe the approach here. 
The GRADE instrument is comprised of eight domains. In each do-
main the starting level of certainty in the evidence was ‘moderate’. In 
five domains: limitations in studies; indirectness; inconsistency; im-
precision; and publication bias the certainty of evidence could be 
downgraded following assessment of the evidence. In three domains: 
large effect size; plausible confounding towards null; and dose–response 
relationship the certainty in the evidence could be upgraded. The 
overall certainty assessment of the body of evidence was then de-
termined by adding together the downgrades and upgrades across do-
mains. An overall rating of high meaning that further research is very 
unlikely to change the confidence in the estimate of the effect; mod-
erate that further research is likely to have an important impact on the 
confidence in the estimate of the effect; low, that further research is 
very likely to have an important impact on the confidence in the esti-
mate of the effect; or very low, meaning that the estimate of the effect is 
very uncertain. Some domains of this tool were evaluated using results 
of the RoB, heterogeneity, sensitivity, and publication bias analyses, 
which were previously described in the methodology. 
A brief outline of each domain is given below: 
Domain 1, limitation in studies, incorporated assessment of RoB, 
with certainty of evidence downgraded only if meta-analysis of studies 
of low RoB differed from meta-analysis of all studies. Hence, the pre-
sence of small studies with high RoB but limited influence on the meta- 
analysis was not a reason to downgrade. 
Domain 2, indirectness, related to how well the PECO in the studies 
in the meta-analysis reflected the original PECO; 
Domain 3, inconsistency domain, addressed heterogeneity using an 
80% prediction interval. The evidence certainty was downgraded if 
substantial heterogeneity was present as indicated by the 80% PI in-
cluding 1 and twice the width of the 95% CI; 
Domain 4, imprecision, was evaluated using sample size calcula-
tions rather than the confidence interval for the pooled estimate since in 
environmental health there are no clinical decision thresholds involved; 
Domain 5, small study bias, assessment was based upon a funnel 
plot and Eggers test used to assess funnel plot asymmetry. The evidence 
certainty was downgraded only if there was clear indication of bias/ 
asymmetry; 
Domain 6, effect size. Potential upgrades to certainty of evidence 
related to effect size was assessed using the E-value calculated with 
increments of 40 μg/m3 and 30 μg/m3 for NO2 and O3 respectively. 
(VanderWeele and Ding, 2017) E-values were not calculated when the 
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Domain 7, statistically significant RR after adjustment for plausible 
confounding. As the omission of potential confounders could alter the 
RR in either direction no upgrading was considered. 
Domain 8, evidence of a dose–response relationship. A RR with 
lower 95% CI above 1 together with evidence from studies that ex-
amined specifically the shape of the concentration response function 
was considered sufficient evidence to upgrade certainty for this domain; 
else no upgrade was applied. 
2.11. Deviations from protocol 
The following deviations from the published protocol were im-
plemented: 
1. STATA program ‘admetan’ used instead of ‘metan’ in order to im-
plement estimation of between study heterogeneity using restricted 
maximum likelihood. This was required as it is acknowledged that 
the method of D&L underestimates tau2. (Veroniki et al., 2016)  
2. O3 studies assign estimated concentrations for annual and ‘peak’ 
periods. As O3 is a seasonal pollutant it is not appropriate to com-
bine study results for the different exposure windows, hence all 
analyses were stratified by annual and warm season exposures. 
3. Results 
3.1. Search strategy 
The search strategies were applied in January 2018 and returned 
2918 studies. One further study not captured by the searches was 
identified from another review. (Atkinson et al., 2018) After combining 
the search results and removal of duplicates, 2068 studies remained for 
screening via title/abstract. The searches were re-run on 11th Sep-
tember 2018 to identify new studies published during the review pro-
cess. After removal of duplicates, this update identified a further 159 
studies for screening of titles/abstracts. The results of the search 
strategy and the screening process are documented in the PRISMA flow 
diagram (Fig. 1). 
3.2. Study selection 
Of the 2068 studies identified in the initial search, 1973 were ex-
cluded after title and abstract screening. The remaining studies 
(n = 95) were subject to full-text assessment. Fifty studies did not meet 
the inclusion criteria (hence 45 studies were included in the review 
(Fig. 1). 
Of the 159 studies identified at the review update in September 
2018, one study was eligible for inclusion in the review. Hence, a total 
of 46 studies were included in the review. Tables 2 and 3 show the 
included studies by exposure and outcome. 
3.3. Description of excluded studies 
Fifty studies did not meet the inclusion criteria and were excluded. 
The reasons for exclusion were: 23 studies did not include the outcome 
of interest; 13 did not report results that can be converted into RR or 
HR; seven replicated results from other papers; five reported results for 
NOx; and two studies were excluded because the assignment of pollu-
tion concentrations were related to length of follow-up. References for 
the excluded studies are listed in Appendix Table B3. 
3.4. Evaluation of included studies 
Of the 46 included studies, 12 studies assessed cohorts recruited 
from patient groups as opposed to the general population (Tables 2 and 
3). Forty-one studies reported risk estimates for NO2 and 20 for O3, 15 
studies reported estimates for both pollutants. About half of the studies 
were from the USA (n = 15) and Canada (n = 7), 19 studies from 
Europe (i.e. UK (n = 5), Netherlands (n = 3), Italy (n = 3), France 
(n = 2), Germany (n = 2), Denmark (n = 1), Norway (n = 1), and 
multiple European study populations (n = 2)), and with remainder 
from China (n = 2) and Japan (n = 3). Forty-two studies reported risk 
estimates for all-cause mortality and 22 for respiratory mortality. All 
cohorts assigned air pollution concentrations to cohort subjects retro-
spectively. Cohort sample size varied from 1800 to 60,000,000. A 
number of cohorts were analysed in more than one study, varying by 
length of follow-up, number of events, and methods used to estimate 
pollution concentrations. A small number of studies used a sub-group of 
subjects taken from a cohort analysed and reported elsewhere or re-
ported a meta-analysis of a number of individual cohorts, some of 
which were published separately. Studies investigating O3 used annual 
concentrations and/or peak season concentrations as the exposure 
metric. Studies included used various methods in exposure assessment, 
including local monitoring networks, atmospheric dispersion models, 
and land use regression model. Outcome (mortality) ascertainment 
methods were similar among studies including national death records, 
insurance records, and hospital records. 
3.5. Risk of bias 
RoB grading for each domain for studies meta-analysed are given in  
Tables 4–6. For the confounding domain most studies were graded 
moderate or high RoB; for the selection bias domain most were graded 
low with only a small number assessed as high/moderate. For all other 
domains, RoB was graded as low for all studies. Details of RoB assess-
ment of individual pollutant-outcome pairs are provided in Appendix C  
Supplementary file. 
3.6. Conflict of interest 
The majority of studies either did not publish a conflict of interest 
statement or declared no conflict. Only a very small number of authors 
declared grant income or additional income and none constituted a 
conflict that warranted sensitivity analyses. 
3.7. Meta-analyses 
3.7.1. Nitrogen dioxide 
3.7.1.1. All-cause mortality. Thirty-six studies reported results for NO2 
and all-cause mortality (Table 2a). One study reported results for two 
separate cohorts. (Health Effects Institute, 2000) Thirteen results were 
excluded from meta-analysis as results from more recent publications 
were available, available for full cohorts, rather than samples, or 
included in the ESCAPE study (see Table 2a for more details). 
Individual study estimates, weights, RE (95% CI) summary estimate, 
model statistics and 80% prediction interval are shown in Fig. 2. A 
10 μg/m3 increase in NO2 was associated with a RR of 1.02 (95% CI: 
1.01, 1.04) for mortality from all-causes. Heterogeneity indicated by I2 
was very high (96.9%). No evidence of small study bias/funnel plot 
asymmetry was found (Egger’s test, P = 0.61, see Fig. B1). The E-value 
was 1.38. 
A slightly larger, more precisely estimated summary RR was ob-
served in general population versus patient cohorts; 1.02 (1.01, 1.04) 
and 1.01 (0.98, 1.04) per 10 μg/m3 respectively (Appendix Fig. B2). 
Meta-analysis stratified by cohorts that controlled for individual mea-
sures of BMI, smoking and SES versus those that did not, reported RR of 
1.03 (1.00, 1.05) and 1.03 (1.03, 1.04) respectively (Appendix Fig. B3). 
Stratification by WHO region is shown in Appendix Fig. B4. Meta-re-
gression including study mean NO2 concentration indicated a negative 
relationship, (-0.00042 (standard error 0.00028) change in ln(RR) per 
unit increase in study mean NO2 concentration. Stratification by RoB 
for the confounding domain (high versus moderate/low) is shown in 
Appendix Fig. B5. Exclusion of the five studies (Table 4a) assessed as 
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Table 4 
RoB assessment for studies included in meta-analysis – NO2. RoB Domains: CO – confounding; SB – selection bias; EA – exposure assessment; OM = outcome 
measurement; MD – missing data; SR – selective reporting.           
a) All-cause 
Author Year Cohort CO SB EA OM MD SR  
Fischer 2015 DUELS mod low low low low low 
Chen 2016 Four northern Chinese cities mod low low low low low 
Bentayeb 2015 Gazel cohort mod mod low low low low 
Desikan 2016 South London Stroke Register high high low low low low 
Beelen 2014 ESCAPE mod low low low low low 
Tonne 2013 MINAP (ACS survivors) mod low low low low low 
Cesaroni 2013 Rome longitudinal study high low low low low low 
Carey 2013 CPRD mod low low low low low 
Hart 2013 Nurses Health Study low low low low low low 
Lipsett 2011 CTS low low low low low low 
Hart 2011 US trucking industry cohort mod low low low low low 
Brunekreef 2009 NLCS-AIR high low low low low low 
Jerrett 2009 Toronto respiratory cohort mod low low low low low 
Rosenlund 2008 CHD survivors cohort high low low low low low 
Lipfert 2006 Washington University-EPRI Veterans mod low low low low low 
Abbey 1999 AHSMOG mod low low low low low 
Weichenthal 2017 CanCHEC high low low low low low 
Hartiala 2016 The Cleveland Clinic GeneBank study mod low low low low low 
Turner 2016 ACS CPS-II mod low low low low low 
Yorifuji 2013 Shizuoka elderly cohort mod mod low low low low 
Filleul 2005 PAARC mod low low low low low 
HEI 2000 Six Cities mod low low low low low 
Yang 2018 Hong Kong elderly mod low low low low low 
Crouse 2015 CanCHEC mod low low low low low           
b) Respiratory 
Author Year Cohort CO SB EA OM MD SR  
Fischer 2015 DUELS mod low low low low low 
Dimakopoulou 2014 ESCAPE mod low low low low low 
Cesaroni 2013 Rome longitudinal study mod low low low low low 
Carey 2013 CPRD mod low low low low low 
Katanoda 2011 3 Japanease Prefectures mod low low low low low 
Lipsett 2011 CTS low low low low low low 
Hart 2011 US trucking industry cohort high low low low low low 
Brunekreef 2009 NLCS-AIR mod low low low low low 
Jerrett 2009 Toronto respiratory cohort mod low low low low low 
Abbey 1999 AHSMOG mod low low low low low 
Weichenthal 2017 CanCHEC high low low low low low 
Turner 2016 ACS CPS-II mod low low low low low 
Yorifuji 2013 Shizuoka elderly cohort mod mod low low low low 
Yang 2018 Hong Kong elderly mod low low low low low 
Crouse 2015 CanCHEC mod low low low low low           
c) COPD 
Author Year Cohort CO SB EA OM MD SR  
Carey 2013 CPRD mod low low low low low 
Katanoda 2011 3 Japanese Prefectures mod low low low low low 
Hart 2011 US trucking industry cohort high low low low low low 
Naess 2007 Oslo Cohort mod low low low low low 
Turner 2016 ACS CPS-II mod low low low low low 
Crouse 2015 CanCHEC mod low low low low low 
Gan 2013 Vancover high low low low low low 
Yorifuji 2013 Shizuoka elderly cohort mod mod low low low low 
Yang 2018 Hong Kong elderly mod low low low low low           
d) ALRI 
Author Year Cohort CO SB EA OM MD SR  
Carey 2013 CPRD mod low low low low low 
Katanoda 2011 3 Japanese Prefectures mod low low low low low 
Turner 2016 ACS CPS-II mod low low low low low 
Yorifuji 2013 Shizuoka elderly cohort mod mod low low low low 
Yang 2018 Hong Kong elderly mod low low low low low    
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high RoB for the confounding domain gave a summary RR for the re-
maining 19 studies of 1.03 (1.01, 1.04) per 10 μg/m3. Of the 24 studies 
included in the meta-analysis, 20 included both male and female par-
ticipants; two included males only, and another two with females only 
(Table 2a). Hence sub-group analysis by sex was not undertaken. Age of 
subjects at cohort entry varied substantially between studies but all 
studies adjusted for age in the analyses. 
3.7.1.2. Respiratory mortality. Nineteen studies reported results for NO2 
and respiratory mortality. Four results were excluded from meta- 
analysis as results from more recent publications were available, or 
included in the ESCAPE study (Table 2b). Individual study estimates, 
weights, RE (95% CI) summary estimate, model statistics and 80% 
prediction interval are shown in Fig. 3. A 10 μg/m3 increase in NO2 was 
associated with a RR of 1.03 (1.01, 1.05) for mortality from respiratory 
disease. Heterogeneity indicated by I2 was high (82.9%). No evidence 
of small study bias/funnel plot asymmetry was found (Egger’s test, 
P = 0.22, Appendix Fig. B6). The E-value was 1.5. 
One of 15 studies reported results from a patient group (Table 2b). 
Stratification by confounding adjustment (Appendix Fig. B7) suggested 
a difference between studies that controlled for individual measures of 
key confounders (1.02 (0.99, 1.05)) compared to those that did not 
(1.04 (1.02, 1.07)). Appendix Fig. B8 presents the results stratified by 
WHO region and clearly illustrates differences between WHO regions – 
summary RR for Eur and AMR were 1.04 (1.00, 1.07) and 1.02 (1.00, 
1.05) compared to 1.07 (0.98, 1.17) per 10 μg/m3 for WPR region. 
Meta-regression including study mean NO2 concentration indicated a 
negative relationship −0.00046 (standard error 0.00020) change in ln 
(RR) per unit increase in study mean NO2 concentration. Exclusion of 
the two studies assessed as high RoB for the confounding domain 
(Table 4b) gave a summary RR for the remaining 13 studies of 1.03 
(1.01, 1.05) per 10 μg/m3 (results not shown). 
3.7.1.3. COPD. Ten studies reported results for NO2 and COPD 
mortality with a single study excluded from the meta-analysis as a 
more recent publication was available (Fig. 4, Table 2c). A 10 μg/m3 
increase in NO2 was associated with a RR of 1.03 (1.01, 1.04) for COPD 
mortality. Heterogeneity indicated by I2 was low (22.7%) and the E- 
value was 1.5. Because of the small number of studies, no sub-group 
analyses were undertaken. Exclusion of the two studies assessed as high 
RoB for the confounding domain (Table 4c) gave a summary RR for the 
remaining seven studies of 1.03 (1.01, 1.05) per 10 μg/m3 (results not 
shown). 
3.7.1.4. Acute lower respiratory infection. Six studies reported results for 
NO2 and ALRI mortality with a single study excluded from the meta- 
analysis as a more recent publication was available (Fig. 5, Table 2d). A 
10 μg/m3 increase in NO2 was associated with a RR of 1.06 (1.02, 1.10) 
for ALRI mortality. Heterogeneity indicated by I2 was 81.3%. Because 
of the small number of studies, no sub-group analyses were undertaken. 
RoB was low/moderate for all domains (Table 4d). The E-value was 1.8. 
3.7.1.5. Minimum concentrations recorded. For NO2 and all-cause 
mortality, 18 out of 24 studies included in the meta-analysis reported 
details of the range of NO2 concentrations in the studies (Table 2). 
Metrics reported included minimum (n = 9) (Crouse et al., 2015a; 
Lipsett et al., 2011; Hartiala et al., 2016; Carey et al., 2013; Filleul 
et al., 2005; Rosenlund et al., 2008; Cesaroni et al., 2013; Chen et al., 
2016; Yorifuji et al., 2013); 5 th percentile (n = 8) (Weichenthal et al., 
2017; Turner et al., 2016; Hart et al., 2011; Hart et al., 2013; Lipfert 
et al., 2006; Fischer et al., 2015; Brunekreef et al., 2009; Yang et al., 
2018)and 25th percentile (n = 1) (Desikan et al., 2015) values of the 
distribution of NO2 concentrations; values ranged from 4.5 μg/m3 
Table 5 
RoB assessment for studies included in meta-analysis – O3 annual average 
concentrations. RoB Domains: CO – confounding; SB – selection bias; EA – 
exposure assessment; OM = outcome measurement; MD – missing data; SR – 
selective reporting.           
a) All-cause 
Author Year Cohort CO SB EA OM MD SR  
Rush 2017 NIS high low mod low low low 
Tonne 2016 MINAP high low low low low low 
Desikan 2016 SLSR high high low low low low 
Carey 2013 CPRD mod low low low low low 
Lipsett 2011 CTS low low low low low low 
Abbey 1999 AHSMOG mod low low low low low 
Turner 2016 ACS CPS II mod low low low low low 
Lipfert 2006 WU-EPRI mod low low low low low 
Krewski 2000 Six Cities mod low low low low low           
b) Respiratory 
Author Year Cohort CO SB EA OM MD SR  
Carey 2013 CPRD mod low low low low low 
Lipsett 2011 CTS low low low low low low 
Abbey 1999 AHSMOG mod low low low low low 
Turner 2016 ACS CPS II mod low low low low low           
c) COPD 
Author Year Cohort CO SB EA OM MD SR  
Carey 2013 CPRD mod low low low low low 
Turner 2016 ACS CPS II mod low low low low low           
d) ALRI 
Author Year Cohort CO SB EA OM MD SR  
Carey 2013 CPRD mod low low low low low 
Turner 2016 ACS CPS II mod low low low low low 
Table 6 
RoB assessment for studies included in meta-analysis – O3 peak concentrations. 
RoB Domains: CO – confounding; SB – selection bias; EA – exposure assessment; 
OM = outcome measurement; MD – missing data; SR – selective reporting.           
a) All-cause 
Author Year Cohort CO SB EA OM MD SR  
Cakmak 2018 CANCHEC mod low low low low low 
Di 2018 MCBS mod low low low low low 
Bentayeb 2015 Gazel cohort mod mod low low low low 
Lipsett 2011 CTS low low low low low low 
Lipfert 2006 WU-EPRI mod low low low low low 
Turner 2016 ACS CPS II mod low low low low low 
Weichenthal 2017 CANCHEC high low low low low low           
b) Respiratory 
Author Year Cohort CO SB EA OM MD SR  
Lipsett 2011 CTS low low low low low low 
Weichenthal 2017 CANCHEC high low low low low low 
Turner 2016 ACS CPS II mod low low low low low 
Crouse 2015 CANCHEC mod low low low low low           
c) COPD 
Author Year Cohort CO SB EA OM MD SR  
Cakmak 2018 CANCHEC mod low low low low low 
Turner 2016 ACS CPS II mod low low low low low           
d) ALRI 
Author Year Cohort CO SB EA OM MD SR  
Turner 2016 ACS CPS II mod low low low low low 
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(Carey et al., 2013) to 81.3 μg/m3 (Chen et al., 2016). For respiratory 
mortality 11 out of 15 studies included in the meta-analysis reported 
details of low NO2 concentrations in the studies (five minimum (Crouse 
et al., 2015a; Lipsett et al., 2011; Carey et al., 2013; Cesaroni et al., 
2013; Yorifuji et al., 2013) and six 5th percentile (Weichenthal et al., 
2017; Turner et al., 2016; Hart et al., 2011; Fischer et al., 2015; 
Brunekreef et al., 2009; Yang et al., 2018) values, ranging from 4.5 μg/ 
m3 to 81.3 μg/m3. Eight of the nine studies of COPD reporting low 
concentrations, five (Crouse et al., 2015a; Carey et al., 2013; Yorifuji 
et al., 2013; Gan et al., 2013; Naess et al., 2007) were for minimum 
Fig. 2. NO2 and all-cause mortality.  
Fig. 3. NO2 and respiratory mortality.  
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concentrations and three (Turner et al., 2016; Hart et al., 2011; Yang 
et al., 2018; Yorifuji et al., 2010) for 5th percentile values. The lowest 
reported concentration was 0 μg/m3 (Crouse et al., 2015a). Two (Carey 
et al., 2013; Yorifuji et al., 2013) of the four studies of ALRI mortality 
reported minimum NO2 concentrations and two (Turner et al., 2016; 
Yang et al., 2018; Yorifuji et al., 2010) reported concentrations for the 
5th percentile with values ranging from 4.5 μg/m3 to 81.3 μg/m3. 
3.7.1.6. Shape of the concentration response function. Naess (Naess et al., 
2007) assessed the relationship between NO2 concentrations and all- 
cause and COPD mortality stratified by age groups (51–70 and 
71–90 years). The authors reported that in younger subjects the risk 
of death from all-causes started to increase from 40 μg/m3 whereas in 
the oldest age group the relationship was linear across the 
concentration range (2–73 μg/m3). Rosenlund (Rosenlund et al., 
Fig. 4. NO2 and COPD mortality.  
Fig. 5. NO2 and ALRI mortality. Cochran's Q: Chi-square = 22.0, df = 4, P = 0.000. tau2 = 0.0014.  
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2008) investigated mortality within 28 days of first coronary events. 
Risk estimates stratified by quintile of NO2 concentration indicated that 
there was no evidence of nonlinearity, although the risk in the 2nd 
quintile was close to 1 and the risk in the top quintile was lower than in 
the 3rd and 4th quintiles. (Raaschou-Nielsen et al., 2012) investigated 
the exposure–response relationship between log2NO2 and all-cause 
mortality using spline functions. They found no evidence to reject a 
linear relationship across the concentration range (5th-95th percentile 
values: 11.6–29.5 μg/m3). Analysis of a 20% sample from the Rome 
longitudinal cohort by Cesaroni (Cesaroni et al., 2013) using natural 
splines showed no evidence of deviation from linearity for all-cause 
mortality and NO2 (minimum concentration approximately 20 μg/m3). 
Fischer (Fischer et al., 2015) assessed the shape of the 
concentration–response relationship for all-cause and respiratory 
mortality using natural splines and tested deviation from linearity 
using the likelihood ratio test. They found no evidence of deviation for 
linearity for either causes of death for NO2 concentrations to 
approximately 10 μg/m3 (5th percentile 19 μg/m3). Naess et al. 
(2007), Gan et al. (2013), Gan et al. (2013) evaluated the 
concentration response relationship using natural cubic spline models 
and reported ‘no discernible exposure–response trends’ for NO2 and 
COPD mortality. None of the studies of ALRI mortality assessed the 
shape of the concentration–response function. 
3.7.1.7. Co-pollutant adjustment. Studies reporting results for NO2 and 
all-cause, respiratory and COPD/ALRI from multipollutant models are 
shown respectively in Appendix Figs. B9-B11. A range of co-pollutants 
were investigated including Black Carbon (Yang et al., 2018; Gan et al., 
2013), particles with a median diameter of < 2.5 μm (PM2.5) (Crouse 
et al., 2015a; Cesaroni et al., 2013; Turner et al., 2016; Yang et al., 
2018; Jerrett et al., 2013; Beelen et al., 2014), sulphur dioxide (SO2) 
(Carey et al., 2013; Chen et al., 2016; Hart et al., 2011) and O3 (Crouse 
et al., 2015a; Carey et al., 2013; Turner et al., 2016; Jerrett et al., 
2013). In some studies associations between NO2 and mortality was 
attenuated upon adjustment for co-pollutants (Carey et al., 2013; 
Turner et al., 2016; Fischer et al., 2015; Beelen et al., 2014) but not 
in others. 
3.7.1.8. Certainty of evidence assessment. Tables 7–10 present the 
certainty of evidence assessments for all-cause, respiratory, COPD and 
ALRI mortality respectively. For NO2 and mortality we assessed the 
certainty of evidence from single pollutant models to be moderate for 
all-causes (mean RR = 1.02 per 10 μ/m3), moderate for respiratory 
(mean RR 1.03 per 10 μ/m3); high for COPD (mean RR = 1.03 per 10 
μ/m3); and moderate for ALRI (mean RR = 1.06 per 10 μ/m3). 
3.7.2. Ozone 
3.7.2.1. All year concentrations 
3.7.2.1.1. All- cause mortality. Twelve studies reported results for 
all-year O3 exposure and all-cause mortality (Table 3a). We selected the 
most recent study results for meta-analyses, therefore three studies 
(Health Effects Institute, 2000; Jerrett et al., 2013; Jerrett et al., 2009) 
were excluded and nine studies (Health Effects Institute, 2000; Lipsett 
et al., 2011; Carey et al., 2013; Turner et al., 2016; Desikan ET AL., 
2015; Abbey et al., 1999; Lipfert et al., 2006; Tonne et al., 2016; Rush 
et al., 2017)were included for main analysis (note: one study (Health 
Effects Institute, 2000) included two cohorts, results from one cohort 
was included, the other was excluded) (Fig. 6). Pooled results showed 
no significant association between increased O3 exposure and all-cause 
mortality, 0.97 (0.93, 1.02) per 10 μg/m3 with large heterogeneity 
(I2 = 98.7%). Publication bias was not assessed due to small number of 
included studies. Exclusion of the three studies (Table 5) with high RoB 
did not materially alter the summary risk (results not shown). 
3.7.2.1.2. Respiratory mortality. Six studies (Lipsett et al., 2011; 
Carey et al., 2013; Turner et al., 2016; Jerrett et al., 2013; Jerrett et al., 
2009; Abbey et al., 1999) reported the all-year O3 exposure and 
respiratory mortality, while four studies (Lipsett et al., 2011; Carey 
et al., 2013; Turner et al., 2016; Abbey et al., 1999) with most recent 
study results were included in the pooled analysis (Table 3b, Fig. 7). No 
significant association was found between increased O3 exposure and 
respiratory mortality, 0.99 (0.89, 1.11) per 10 μg/m3. 
3.7.2.1.3. COPD. Only two studies reported the association 
between annual O3 exposure and COPD mortality (Table 3c). Turner 
2016 (Turner et al., 2016) showed that increased O3 exposure was 
associated with higher risk of COPD mortality, 1.07 (1.04, 1.10) per 
10 μg/m3, while Carey 2013 (Carey et al., 2013) found no significant 
association between O3 exposure and risk of COPD mortality. 
3.7.2.1.4. Acute lower respiratory Infection. Two studies reported O3 
exposure and risk of ALRI mortality (Table 3d). Turner 2016 (Turner 
et al., 2016) showed that increased O3 exposure was associated with a 
higher risk of mortality, 1.07 (1.04, 1.11) per 10 μg/m3 while Carey 
2013 (Carey et al., 2013) found the association was in the opposite 
Table 7 
GRADE assessment – NO2 and all-cause mortality.     
Domain Judgement Down/Up Grade  
Limitations in studies 24 included studies. Risk of bias moderate because although not all studies adjusted for 
all confounders, exclusion of high risk of bias studies did not reduce the summary RR 
(Appendix Fig. B5). 
No downgrading 
Indirectness All studies included the desired population, exposures and outcomes No downgrading 
Inconsistency The 80% prediction interval included 1 &  >  twice CI (Fig. 2). High level of 
heterogeneity in general population studies. Studies controlling for individual 
measures of BMI, smoking, SES (Appendix Fig. B3) gave slightly higher, less precise 
summary RR. Exclusion of patient cohorts (6) did not change summary RR & CI 
(Appendix Fig. B2). 
Downgrade one level 
Imprecision The number of person years in the included studies was greater than 940 000 No downgrading 
Publication Bias According to the funnel plot and Egger’s test (P  <  0.1), there were no sign of 
publication bias/funnel plot asymmetry. 
No downgrading 
Large Effect Size Summary RR = 1.02. Precision reduced for cohorts with all individual confounder 
adjustment but not summary estimate. Insufficient information on unmeasured 
potential confounders available. 
No upgrading 
Plausible confounding towards 
null 
Confounding direction unknown but precision may be affected. No upgrading 
Dose-response relation A linear dose–response relationship was assumed in all studies. 5 studies investigated 
the shape of the dose response relationship with no evidence to suggest non-linear. 
95% CI for linear RR excluded 1. 
Upgrade one level 
GRADE conclusion Downgrade one level and upgrade one level MODERATE CERTAINTY 
EVIDENCE MEAN RR UNADUSTED FOR 
CO-POLLUTANTS EQUALS 1.02 PER 10μ/m3 
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direction, 0.84 (0.73, 0.97) per 10 μg/m3. 
3.7.2.2. Peak exposures 
3.7.2.2.1. All- cause mortality. Twelve studies (Crouse et al., 2015a; 
Lipsett et al., 2011; Weichenthal et al., 2017; Turner et al., 2016; Lipfert 
et al., 2006; Lipfert et al., 2006; Bentayeb et al., 2015; Cakmak et al., 
2018; Di et al., 2017; Krewski et al., 2009; Smith et al., 2009; Cakmak 
et al., 2016) reported the association between warm season O3 exposure 
and all-cause mortality. Seven studies (Lipsett et al., 2011; Weichenthal 
et al., 2017; Turner et al., 2016; Lipfert et al., 2006; Bentayeb et al., 
2015; Cakmak et al., 2018; Di et al., 2017) with most recent cohort 
results were included for pooled analysis (Table 3a). Meta-analysis 
result showed that a 10 μg/m3 increase in O3 exposure was associated 
with a RR of 1.01 (1.00, 1.02) per 10 μg/m3 for all-cause mortality 
although the heterogeneity was high among studies (I2 = 98%) (Fig. 8). 
Exclusion of the single study judged high RoB for confounding domain 
(Table 6) did not change the summary RR and CI (results not shown). 
The E-value was 1.25. 
3.7.2.2.2. Respiratory mortality. Five studies (Crouse et al., 2015a; 
Lipsett et al., 2011; Weichenthal et al., 2017; Turner et al., 2016; Smith 
et al., 2009) reported the association between warm season O3 exposure 
and respiratory mortality, and four studies (Crouse et al., 2015a; Lipsett 
et al., 2011; Weichenthal et al., 2017; Turner et al., 2016) with most 
recent results were included in the pooled analysis (Table 3b). Meta- 
analysis showed that increased O3 exposure was associated with an 
increased risk of respiratory mortality, 1.02 (0.99, 1.05) per 10 μg/m3 
(Fig. 9). Exclusion of the single study judged high RoB for confounding 
domain (Table 6) did not change the summary RR and CI (results not 
shown). The E-value was 1.38. 
3.7.2.2.3. COPD. Only two studies reported the warm season O3 
exposure with COPD mortality (Table 3c). Turner 2016 (Turner et al., 
2016) showed that increased O3 exposure was associated with higher 
risk of COPD mortality, while Cakmak 2018 (Cakmak et al., 2018) 
found no significant association between O3 exposure and COPD 
mortality. 
3.7.2.2.4. Acute lower respiratory infection. Only a single study 
reported results for O3 peak exposure and ALRI mortality (Table 3d). 
Turner (Turner et al., 2016) found that a 10 ppb increase in O3 was 
associated with a RR of 1.10 (1.03, 1.18). 
3.7.2.3. Minimum concentrations recorded. Minimum O3 concentrations 
were recorded in 6 of 21 studies; 5th percentile in 5 of 21; 25th 
percentile in 1 of 21; and not recorded in 9 of 21 studies (Table 3). The 
lowest minimum and 5th percentile concentrations values in annual 
exposure studies were 44 μg/m3 and 57 μg/m3 respectively. In ‘peak’ 
season studies, the corresponding values were 21 μg/m3 and 30 μg/m3. 
3.7.2.4. Shape of the concentration response function. A small number of 
studies examined the shape of the concentration response relationships 
for O3 and mortality. Turner 2016 (Turner et al., 2016) analysing the 
American Cancer Society (ACS) cohort reported evidence that a 
threshold model (35 ppb) offered an improved fit over the linear 
Table 8 
GRADE assessment – NO2 and respiratory mortality.     
Domain Judgement Down/Up Grade  
Limitations in studies 15 included studies. Risk of bias moderate because although not all studies adjusted for all 
confounders, exclusion of high risk of bias studies did not alter summary RR. 
No downgrading 
Indirectness All studies included the desired population, exposures and outcomes No downgrading 
Inconsistency The 80% prediction interval included 1; PI = 2 × CI (Fig. 3). Studies controlling for 
individual measures of BMI, smoking, SES gave lower summary RR and CI included 1 
(Appendix Fig. B7). Exclusion of single patient cohort did not change summary RR & CI. 
High level of heterogeneity in general population studies 
Downgrade one level 
Imprecision The number of person years in the included studies was greater than 940 000 No downgrading 
Publication Bias According to the funnel plot little evidence of publication bias No downgrading 
Large Effect Size Summary RR = 1.03Insufficient information on unmeasured potential confounders 
available 
No upgrading 
Plausible confounding towards 
null 
Confounding direction unknown but precision may be affected No upgrading 
Dose-response relation A linear dose–response relationship was assumed in all studies, 95% CI for linear RR 
excluded 1. No evidence to confirm shape of the dose response relationship. 
Upgrade one level 
GRADE conclusion No downgrade and no upgrade MODERATE CERTAINTY 
EVIDENCE MEAN RR UNADUSTED FOR 
CO-POLLUTANTS EQUALS 1.03 PER 10μ/m3 
Table 9 
GRADE assessment – NO2 and COPD mortality.     
Domain Judgement Down/Up Grade  
Limitations in studies 9 included studies. Risk of bias moderate because although not all studies adjusted for all 
confounders, exclusion of 2 high risk of bias studies did not alter summary RR. 
No downgrading 
Indirectness All studies included the desired population, exposures and outcomes No downgrading 
Inconsistency The 80% prediction interval did not include 1 (Fig. 4) No downgrading 
Imprecision The number of person years in the included studies was greater than 940 000 No downgrading 
Publication Bias No analysis of publication bias – too few studies (n = 9) No downgrading 
Large Effect Size Summary RR = 1.02 Insufficient information on unmeasured potential confounders 
available 
No upgrading 
Plausible confounding towards 
null 
Confounding direction unknown but precision may be affected No upgrading 
Dose-response relation A linear dose–response relationship was assumed in all studies, 95% CI for linear RR 
excluded 1. 2 studies investigated the shape of the dose response relationship with no 
evidence to suggest non-linear 
Upgrade one level 
GRADE conclusion No downgrade and upgrade one level HIGH CERTAINTY EVIDENCE 
MEAN RR UNADUSTED FOR CO-POLLUTANTS 
EQUALS 1.03 PER 10μ/m3 
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model for annual O3 concentrations and both respiratory and 
cardiovascular mortality (Rush et al., 2017). Using thin-plate–spline 
models, Di (Di et al., 2017) reported a relationship between O3 and all- 
cause mortality that was almost linear, with no signal of a threshold 
down to 30 ppb. 
3.7.2.5. Co-pollutant adjustment. A small number of studies reported 
results for O3 and mortality from multipollutant models (Appendix Figs. 
B12 and B13). A range of co-pollutants were investigated including 
Black Carbon, PM2.5, SO2 and NO2 in two- and three-pollutant models. 
Associations between O3 and mortality were attenuated upon 
adjustment for co-pollutants in some studies but not in others and no 
discernible pattern between unadjusted and adjusted studies was 
observed. 
3.7.2.6. Certainty of evidence assessment. Certainty of evidence 
assessments were completed for studies using annual and peak O3 
concentrations and all-cause and respiratory mortality (Tables 11–14). 
Too few studies were available for COPD and ALRI mortality for GRADE 
assessment. For studies reporting annual O3 metrics we assessed the 
certainty of the evidence from single pollutant models to be low for all- 
cause mortality (mean RR 0.97 per 10μ/m3); and low for respiratory 
mortality (mean RR 0.99 per 10μ/m3). For peak O3 exposures we 
assessed the certainty of evidence from single pollutant models to be 
moderate for all-cause mortality (mean RR 1.01 per 10μ/m3) and low 
for respiratory mortality (mean RR 1.02 per 10μ/m3). 
3.8. New studies published after final search 
We rapidly reviewed studies (n = 5) that published since our last 
search (Appendix Table B4). Two studies were conducted in the USA, 
NIH-AARP (Lim et al., 2019) and Medicare beneficiaries 
(Kazemiparkouhi et al., 2019); two studies conducted in Europe, in-
cluding Danish Diet, Cancer and Health (Hvidtfeldt et al., 2019) cohort 
Table 10 
GRADE assessment – NO2 and ALRI mortality.     
Domain Judgement Down/Up Grade  
Limitations in studies 5 included studies. Risk of bias moderate for all studies, not all studies adjusted 
for all confounders. 
No downgrading 
Indirectness All studies included the desired population, exposures and outcomes No downgrading 
Inconsistency The 80% prediction interval included 1 but the PI was not  >  2 × CI (Fig. 5). 
Substantial heterogeneity amongst small number of studies. 
Downgrade one level 
Imprecision The number of person years in the included studies was greater than 940 000 No downgrading 
Publication Bias No analysis of publication bias – too few studies No downgrading 
Large Effect Size Summary RR = 1.02 Insufficient information on unmeasured potential 
confounders available 
No upgrading 
Plausible confounding towards 
null 
Confounding direction unknown but precision may be affected No upgrading 
Dose-response relation No information on shape. 95% CI for linear RR excluded 1. Upgrade one level 
GRADE conclusion No downgrade and no upgrade MODERATE CERTAINTY 
EVIDENCE MEAN RR UNADUSTED FOR CO-POLLUTANTS 
EQUALS 1.06 PER 10μ/m3    
Fig. 6. O3 annual exposure and all-cause mortality. Cochran's Q: Chi-square = 98.7, df = 8, P  <  0.001. tau2 = 0.004.  
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and Dutch National Health Survey cohort (Klompmaker et al., 2020) 
follow-up; and the “45 and up” cohort based in Australia (Hanigan 
et al., 2019). All studies were conducted among general population 
rather than patient cohort. 
Among the new studies, four explored the association between NO2 
and all-cause mortality, two reported results consistent with our pooled 
analyses (Lim et al., 2019; Hvidtfeldt et al., 2019); an Australian study 
reported an association in the same direction (Hanigan et al., 2019), 
while another Dutch study showed no clear association which may due 
to relatively shorter period of follow up (Klompmaker et al., 2020). 
Three studies investigated the impact of NO2 exposure on respiratory 
mortality: two showed a consistent direction of association (Lim et al., 
2019; Hvidtfeldt et al., 2019) while no clear association was found in 
the Dutch cohort (Klompmaker et al., 2020). Lim 2019 also found 
Fig. 7. O3 annual exposure and respiratory mortality. Cochran's Q: Chi-square = 19.4, df = 3, P  <  0.001. tau2 = 0.012.  
Fig. 8. O3 peak exposure and all-cause mortality. Cochran's Q: Chi-square = 78.48, df = 6, P  <  0.001. tau2 = 0.0002.  
P. Huangfu and R. Atkinson   Environment International 144 (2020) 105998
19
adverse associations for NO2 concentrations and ALRI mortality, while 
the association was less clear for COPD mortality (Lim et al., 2019). 
Lim et al. (Lim et al., 2019) and Hvidtfeldt et al. (Hvidtfeldt et al., 
2019) both found no clear association between annual O3 concentra-
tions and all-cause mortality, which was consistent with our summary 
estimates; while Hvidtfeldt et al found an adverse association between 
annual O3 concentrations and respiratory, COPD, but not ALRI mor-
tality. Kazemiparkouhi et al. (Kazemiparkouhi et al., 2019) found warm 
season O3 exposure increased the risk of all-cause, respiratory, and 
COPD mortality among Medicare beneficiaries. Lim et al showed con-
sistent results for respiratory and COPD mortality, but adverse asso-
ciations with all-cause and ALRI mortality which were of borderline 
statistical significance (Lim et al., 2019). In summary, most of the 
newly published studies reported similar effect estimates compared to 
our summary estimates, therefore our pooled estimates is unlikely to be 
altered by the small number of newly published studies. 
4. Discussion 
4.1. Summary of evidence and comparison with existing literature 
4.1.1. Nitrogen dioxide 
The review identified 41 articles reporting results for NO2 and 
mortality. Associations with mortality were positive; RR (95% CI) were 
1.02 (1.01, 1.04); 1.03 (1.01, 1.05); 1.03 (1.01, 1.04); and 1.06 (1.02, 
1.10) per 10 μg/m3 for all-cause, respiratory, COPD and ALRI mortality 
respectively. The review identified high levels of heterogeneity, as in-
dicated by the I2 statistic, together with a wide variation between 
studies in the magnitude and precision of the associations for most 
pollutant/outcome pairs. 
Reviews published in 2013 (Hoek et al., 2013); 2014 (Faustini et al., 
2014) and 2018 (Atkinson et al., 2018) have assessed the growing lit-
erature on NO2 and mortality. The evidence base continues to be 
dominated by studies from North America and Europe. Furthermore, a 
number of the more recent studies included re-analyses of existing 
Fig. 9. O3 peak exposure and respiratory mortality.  
Table 11 
GRADE assessment – O3 annual exposure and all-cause mortality.     
Domain Judgement Down/Up Grade  
Limitations in studies 9 included studies. 3 studies with a total weight of 28% in the meta-analysis had high 
risk of bias. Excluding these studies did not change significantly the summary RR (text). 
No downgrading 
Indirectness 1 study with study sample of stroke patients based in London. However, it was a small 
study and only carried 1% weight 
No downgrading 
Inconsistency The 80% prediction interval included 1 & PI  >  2 × CI (Fig. 6). Downgrade one level 
Imprecision The number of person years in the included studies was greater than 940 000 No downgrading 
Publication Bias No analysis of publication bias – too few studies (n = 9) No downgrading 
Large Effect Size Summary RR = 0.97 No upgrading 
Plausible confounding towards 
null 
Confounding direction unknown but precision may be affected No upgrading 
Dose-response relation A linear dose–response relationship was assumed in all studies. 95% CI for linear RR 
included 1. None of the studies reported the dose–response relationship 
No upgrading 
GRADE conclusion Downgrade one level and no upgrade LOW CERTAINTY EVIDENCE 
MEAN RR UNADUSTED FOR CO-POLLUTANTS 
EQUALS 0.97 PER 10μ/m3 
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cohorts. The summary RR for all-cause mortality from this review is 
broadly comparable to previous reviews; Faustini et al. (Faustini et al., 
2014) assessed 12 studies that also included results for particulate 
matter and reported a summary HR (per 10 μg/m3) of 1.04 (1.02, 1.06) 
; Hoek et al. (Hoek et al., 2013) assessed 11 cohorts, summary 
HR = 1.06 (1.04, 1.08); and Atkinson et al. (Atkinson et al., 2018) 23 
cohorts with a summary HR = 1.02 (1.01, 1.03). For respiratory 
mortality, Atkinson et al. (Atkinson et al., 2018) reported a RE sum-
mary HR of 1.03 (1.01, 1.05) per 10 μg/m3 increment in NO2 based 
upon 13 studies - the addition of two further studies for this review did 
not materially alter the summary estimate. Similarly, as few additional 
studies reporting results for COPD were available, the results from this 
review and Atkinson et al. (Atkinson et al., 2018) were very similar. 
4.1.2. Ozone 
The review identified 20 articles reporting results for O3 and mor-
tality. The majority of the evidence came from cohorts in North 
America and Europe. A number of cohorts were analysed more than 
once hence reducing the number of independent estimates available for 
meta-analyses. Studies also differed in the O3 metric used; in some 
studies, O3 concentrations were calculated for ‘peak’ or warm season 
months only, whereas others used annual metrics. Combining studies 
using annual and peak O3 metrics was not considered appropriate be-
cause the lowest O3 concentrations are unlikely to occur during ‘peak’ 
O3 months; and secondly correlations between O3 and other pollutants 
are known to vary by ‘season’. 
The associations between annual O3 and mortality were 0.97 (0.93, 
1.02) and 0.99 (0.89, 1.11) per 10 μg/m3 for all-cause and respiratory 
mortality respectively. The review identified high levels of hetero-
geneity, as indicated by the I2 statistic. Few studies investigated the 
shape of the concentration–response relationship. 
Reviews of the health effects of long-term exposure to O3 are lim-
ited. Early reviews have provided narrative assessments of the cohort 
literature as part of more comprehensive assessments of the epide-
miological and toxicological literature (WHO, 2013; EPA US, 2013). A 
quantitative review in 2016 (Atkinson et al., 2016) found a limited 
number of studies for synthesis: no evidence of associations between 
long-term annual O3 concentrations and all-cause and respiratory 
mortality were found, a result confirmed in this review. The 2016 re-
view and this review using updated analyses from the ACS and Can-
CHEC cohorts differed in their findings for peak season concentrations 
of O3 and all-cause and respiratory mortality. 
4.2. Heterogeneity 
Heterogeneity is an indicator of the extent to which variation be-
tween study estimates is too great to be explained by chance. Large 
variations in study sample sizes/number of events (as for most out-
comes included in this review) can lead to an artificially high I2 sta-
tistic, a measure of heterogeneity (IntHout et al., 2016). The I2 statistic 
does not provide information about the range of the size of the esti-
mates in a meta-analysis; for this purpose the forest plots and prediction 
intervals are more informative (Borenstein et al., 2017). One con-
sequence of the high levels of heterogeneity and variation in the size of 
study estimates found in the evidence assembled for this review is that a 
random effects model is preferable to a fixed effects model for the meta- 
Table 12 
GRADE assessment – O3 annual exposure and respiratory mortality.     
Domain Judgement Down/Up Grade  
Limitations in studies Only 4 studies; all rated low or moderate risk of bias No downgrading 
Indirectness All studies included the desired population, exposures and outcomes No downgrading 
Inconsistency The 80% prediction interval included 1 & PI  >  2 × CI (Fig. 7). Substantial 
heterogeneity amongst small number of studies. 
Downgrade one level 
Imprecision The number of person years in the included studies was greater than 940 000 No downgrading 
Publication Bias No analysis of publication bias – too few studies (n = 4) No downgrading 
Large Effect Size Summary RR = 0.99 No upgrading 
Plausible confounding towards 
null 
Confounding direction unknown but precision may be affected. No upgrading 
Dose-response relation A linear dose–response relationship was assumed in all studies. 95% CI for linear RR 
included 1. None of the studies reported dose–response relationship. 
No upgrading 
GRADE conclusion Downgrade one level and no upgrade LOW CERTAINTY EVIDENCE 
MEAN RR UNADUSTED FOR CO-POLLUTANTS 
EQUALS 0.99 PER 10μ/m3 
Table 13 
GRADE assessment – O3 peak exposure and all-cause mortality.     
Domain Judgement Down/Up Grade  
Limitations in studies 7 included studies. 1 study with high risk of bias- exclusion did not change 
summary RR (text). 
No downgrading 
Indirectness 1 study might have introduced some selection bias due to the volunteering 
sample chosen. However, it was only weighted at  < 2% among all studies. 
No downgrading 
Inconsistency The 80% prediction interval included 1; PI = 2 × CI (Fig. 8) No downgrading 
Imprecision The number of person years in the included studies was greater than 940 000. No downgrading 
Publication Bias No analysis of publication bias – too few studies (n = 6) No downgrading 
Large Effect Size Summary RR = 1.01. All critical confounders were adjusted for. Insufficient 
information on unmeasured potential confounders available 
No upgrading 
Plausible confounding towards 
null 
Confounding direction unknown but precision may be affected. No upgrading 
Dose-response relation A linear dose–response relationship was assumed in all studies. 95% CI for linear 
RR included 1. 1 study investigated the shape of the dose response relationship 
with no evidence to suggest non-linear. 
No upgrading 
GRADE conclusion No downgrade and no upgrade MODERATE CERTAINTY EVIDENCE MEAN RR 
UNADUSTED FOR CO-POLLUTANTS EQUALS 1.01 PER 
10μ/m3 
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analysis. This random effect model assumes a distribution of true po-
pulation associations; that is the magnitude of the association between 
pollutant and mortality in one study population is different to another 
study population. However, as NO2 and O3 are gases, and therefore the 
same compositions in all study locations, it could be argued that a 
random effects model is not appropriate. The variation between the 
observed associations may arise because of differences between study 
characteristics (e.g. study population, adjustment for confounders, 
spatial resolution of the pollution models, co-pollutants or analytical 
methods employed) and should be (mostly) explainable using meta- 
regression techniques provided the appropriate data and sufficient 
numbers of studies are available. None of the factors available in this 
review explained fully the observed heterogeneity. Further investiga-
tion is needed therefore to inform the appropriate interpretation of the 
evidence in this review (Egger et al., 1998). 
4.3. Concentration response functions 
Only a small number of studies investigated the shape of the con-
centration–response function. In general, these studies found limited 
evidence to reject the assumption of linearity. A statistically significant 
linear regression coefficient (log-scale) is indicative of an important 
concentration response function but does not inform of the actual shape 
of the relationship, the existence of a threshold or whether the asso-
ciation is present for a given pollutant concentration range. The ma-
jority of included studies did not indicate whether the shape of the 
relationship was investigated prior to fitting a linear model. The 
minimum or 5th percentile values of the distributions of the pollutant 
concentrations provide an indication of the lower concentrations in-
cluded in the set of observations to which a linear model was fitted. 
This is not the same as saying the concentration–response relationship 
is linear down to these concentrations. A linear model will fit a linear 
relationship between two variables irrespective of whether not the ex-
posure variable and the outcome are linearly related. Furthermore, data 
are often sparse at the extremes of the pollutant distributions and 
therefore the corresponding prediction intervals wide. Caution is 
therefore required when interpreting the results from linear models in 
relation to the range of observed concentrations. 
Even for studies that only reported results from linear models, the 
distribution of the pollutant concentrations is not always reported. In 
such cases authors were contacted by email and asked to provide the 
relevant data with variable response. Hence, in a sizeable proportion of 
the studies, the 5th percentile/minimum pollutant concentrations are 
missing. Moreover, studies from geographical regions with high levels 
of pollutants comprised a small proportion in our review, but with vast 
majority of studies from countries with low-middle range of pollutant 
concentration. These gaps make interpretation of the evidence more 
difficult. Given the importance of both the shape of the concentration 
response function and the range of observed concentrations to the 
achievement of the review objective, a strategy for evidential judge-
ment is required. For example, should guideline recommendations be 
based upon only those studies with complete data and have specifically 
set out to evaluate the shape of the concentration response function? 
4.4. Multi-pollutant models 
Assessment of the impact of co-pollutants on the associations be-
tween NO2 and O3 and mortality was limited by the small number of 
studies reporting results from two-pollutant models and the high cor-
relation between pollutants in some studies. The difficulties in inter-
preting coefficients in multi-pollutant models are well recognised 
(Greenbaum and Shaikh, 2010; Dominici et al., 2010) and include high 
correlation between pollutants (limiting the ability of two-pollutant 
models to separate out associations) leading to unstable parameter es-
timation; differential measurement error between pollutants which can 
lead to the ‘transfer’ of an association from the less well measured (but 
true) pollutant to the better measured (but incorrect) pollutant; and 
finally analysts rarely assess interactions between pollutants which is 
necessary to interpret correctly model main effects. Some investigators 
have proposed methods for dealing with correlated predictors, for ex-
ample composite hazard ratios for more than one pollutant. An as-
sessment of results from multi-pollutant models should consider 
changes in risk estimates from single and multi-pollutant pollutants for 
each pollutant jointly, not individually (Dominici et al., 2010). The 
relatively small numbers of studies reporting results from multi-pollu-
tant models limits out assessment of these issues. Caution should be 
exercised therefore when interpreting results from single pollutant 
models as reported associations may reflect pollutant mixtures rather 
than individual pollutants per se. 
4.5. Strengths and limitations 
This review uses a comprehensive search strategy applied to three 
databases and updated to include more recent publications. It also in-
cludes a narrative assessment of the evidence for the shape of the 
concentration response function for both NO2 and O3 and consideration 
of results from multi-pollutant models. A key strength of the review 
involved the application of new RoB and GRADE tools developed spe-
cifically for application in environmental epidemiology. 
In common with many reviews of cohort studies of outdoor air 
pollutants and mortality the evidence base can be limited both in terms 
of the number of independent cohorts and their geographical spread. 
These limitations may restrict the applicability of the review findings 
worldwide. The number of available cohorts also precludes meaningful 
Table 14 
GRADE assessment – O3 peak exposure and respiratory mortality.     
Domain Judgement Down/Up Grade  
Limitations in studies 4 included studies. 1 study high risk of bias. Exclusion did not alter significantly 
the RR and CI (text). 
No downgrading 
Indirectness All studies included the desired population, exposures and outcomes No downgrading 
Inconsistency The 80% prediction interval included 1; PI = 2 × CI (Fig. 9). Substantial 
heterogeneity amongst small number of studies. 
Downgrade one level 
Imprecision The number of person years in the included studies was greater than 940 000 No downgrading 
Publication Bias No analysis of publication bias – too few studies (n = 3) No downgrading 
Large Effect Size Summary RR = 1.02. Insufficient information on unmeasured potential 
confounders available 
No upgrading 
Plausible confounding towards 
null 
Confounding direction unknown but precision may be affected. No upgrading 
Dose-response relation A linear dose–response relationship was assumed in all studies. 95% CI for linear 
RR included 1. 1 study investigate the dose–response relationship. No evidence to 
confirm shape of the dose response relationship for Ozone exposure 
No upgrading 
GRADE conclusion No downgrade and no upgrade LOW CERTAINTY EVIDENCE MEAN RR UNADUSTED 
FOR CO-POLLUTANTS EQUALS 1.02 PER 10μ/m3 
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meta-regression to explore causes of heterogeneity. Whilst sub-group 
analysis, even a priori sub-group analysis, is useful to explore differ-
ences between studies, it is a univariate procedure and does not rule out 
the possibility of group differences arising due to other confounding 
factors. 
This review of associations between NO2 and O3 and mortality in 
epidemiological cohort studies provides evidence for the assessment of 
the strength of evidence for associations only. It has focused on results 
form single pollutant models. The question of the independence of these 
associations from other pollutants requires careful consideration. A 
separate causal determination is required to proceed to quantification 
of health impacts. 
Hazard ratios from cohort studies are typically small. The choice of 
studies for meta-analyses can have a relatively large impact on the 
summary HRs. Because of the ubiquitous nature of exposure to outdoor 
air pollution, small HRs derived from reviews of this kind, can have a 
substantial estimated health impact because of the large populations 
exposed. The review protocol including decisions on study selection 
relating to confounder adjustment, patient vs general population co-
horts, spatial resolution of the air pollution models will have a major 
bearing on the included studies, the meta-analytical estimates and 
consequently health impact assessments. For these reasons the predic-
tion intervals provide useful and important information regarding the 
range of the risk estimates in the studied populations. 
The RoB tool was discriminatory for a small number of studies in the 
confounding domain only and all but a very few studies were rated low 
for other domains. One possible explanation for this lack of dis-
crimination is that the included studies are of a high quality and at low 
risk of bias. Another is that the RoB tool is not sensitive enough to assess 
the risk of potential biases in the literature. For example, the bias as-
sessment in the confounding domain relied upon the inclusion/exclu-
sion of a set of critical and potential confounders in the studies. The list 
of potential confounders was long and lead to most studies being rated 
as moderate risk of bias. The RoB tool used in this review was recently 
developed for environmental epidemiology, therefore we cannot rule 
out the potential misapplication of the new tool at this stage. However, 
the new RoB tool does provide a framework to assess bias in the in-
cluded literature systematically. Future development of the tool could 
further improve its capacity to recognise the flaws in study design and 
report which potentially attenuate the effect observed. 
There remains no widely accepted GRADE-like system to assess 
evidence in observational studies in environmental health. The adapted 
GRADE framework used in this review was less strict than the standard 
GRADE. The modified framework, which was developed by methodol-
ogists and experts in environmental epidemiology, is a step towards 
achieving a robust set of criteria for evidence evaluation. However, it is 
not without its difficulties. The development of the tool was a lengthy 
process with differences between group members relating to the detail 
and application of the tool. The use of the E-value (VanderWeele and 
Ding, 2017), derived from the summary risk ratio in a meta-analysis, to 
assess the size of associations reported in cohort studies remains pro-
blematical because some cohorts control for most critical and potential 
confounders. Determining a potential unmeasured confounder is 
therefore not straightforward, nor is finding the relevant literature with 
which to assess the degree of potential confounding. Furthermore, the 
E-value is not without its critics (Ioannidis et al., 2019). Another 
challenging aspect of the tool is the assessment of small study bias in 
the presence of heterogeneity (Peters et al., 2010). In this respect we 
have been circumspect in the application of this specific GRADE cri-
terion, interpreting both the funnel plot and the result of the Eggers test 
with caution. The criterion that the 80% prediction interval is twice the 
confidence interval and contains unity was also new. Where the body of 
evidence is heterogeneous and a wide range in the magnitude of 
associations is observed, this criterion downgrades the certainty of 
evidence on the basis that there may exist one (or more) populations in 
which an adverse association is not found. There may well be positive 
associations in other populations however. During the development of 
the tool there was discussion on whether this rule should be strictly 
applied or whether a more flexible application was appropriate. We 
therefore applied downgrading in this domain only when the 80% PI 
contained unity and did not downgrade when the ratio was marginal 
(the CI are approximately symmetrical about the point estimate on the 
relative risk scale when the risks are small). Exclusion of the few, high 
RoB studies did not lead to major changes in the summary risk ratios 
and hence did not indicate a downgrade for the domain, though this is 
perhaps not surprising given the small risks reported in many air pol-
lution cohort studies and the relative imprecision of some studies. 
5. Conclusion 
This review of cohort studies found positive associations between 
long-term concentrations of NO2 and mortality and limited evidence for 
O3 and mortality. However, there was very high levels of heterogeneity 
between study estimates giving rise to 80% prediction intervals that 
included the null for most pollutant-outcome pairs with insufficient 
studies to explore reasons using meta-regression. Relatively few studies 
reported results from multi-pollutant models. 
For NO2 and mortality we assessed the certainty of evidence 
(adapted GRADE) from single pollutant models to be moderate for all- 
causes (mean RR = 1.02 per 10 μ/m3), moderate for respiratory (mean 
RR 1.03 per 10 μ/m3); high for COPD (mean RR = 1.03 per 10 μ/m3; 
and moderate for ALRI (mean RR = 1.06 per 10 μ/m3). For studies 
reporting annual O3 metrics we assessed the certainty of the evidence 
from single pollutant models to be low for all-cause mortality (man 
RR = 0.97 per 10 μ/m3); and low for respiratory mortality (mean 
RR = 0.99 per 10 μ/m3). For peak O3 exposures we assessed the cer-
tainty of evidence from single pollutant models to be moderate for all- 
cause mortality (mean RR = 1.01 per 10 μ/m3) and low for respiratory 
mortality (mean RR = 1.02 per 10 μ/m3). 
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Appendix A. WHO GRADE guidance 
Approach to assessing the certainty of evidence from systematic reviews informing WHO global air quality guidelines 
By: The WHO global air quality guidelines Working group on certainty of evidence assessment 
Acknowledgements 
This supplementary material consists of an approach to assessing the certainty of evidence from systematic reviews of epidemiologic studies of air 
quality and health, based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework. 
The approach was developed by external methodologist Jos Verbeek (Cochrane Work), with inputs from the WHO Global Air Quality Guidelines 
Working Group on Certainty of Evidence Assessment, convened by the WHO European Centre for Environment and Health (WHO Regional Office for 
Europe) in the context of the forthcoming WHO global air quality guidelines. The Working Group was composed of the Guideline Development 
Group members: Aaron Cohen (Health Effects Institute), Bert Brunekreef (Utrecht University), Francesco Forastiere (King’s College London), Nino 
Künzli (Swiss Tropical and Public Health Institute), and external methodologist: Rebecca Morgan (McMaster University); and, from the staff of the 
WHO Regional Office for Europe: Román Pérez-Velasco, Hanna Yang and Dorota Jarosińska. Additional comments were provided at different stages 
by external methodologist Eva Rehfuess (Cochrane Public Health Europe) and GDG members Michal Krzyzanowski (King’s College London), and 
Jonathan Samet (Colorado School of Public Health). 
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Background 
The Grading of Recommendations Assessment, Development and Evaluation (GRADE) has been developed to standardize the approach to judging 
the certainty of the effects of interventions (Schunemann et al., 2013). As such, the approach is currently the basis for evidence review in support of 
WHO Guidelines (World Health Organization, 2014). 
The main value of the system is that the comparability of the judgements increases when all assessors consider the same arguments underpinning 
their certainty in a similar manner. That is how the factors for downgrading and upgrading the certainty have been developed: to guide expert 
judgement. Behind each down- and upgrading factor in GRADE, there is a rationale for its importance and guidance for elaborating good reasons for 
downgrading or not downgrading. These ideas are well explained in the GRADE Handbook (Schunemann et al., 2013). Most of the reasoning in this 
framework can be equally well used for observational studies of exposure as for randomized studies of interventions (Morgan et al., 2016). However, 
at some points there is a need for elaboration or clarification on how to use the GRADE criteria for observational studies of exposure. 
Although different groups have adapted the approach for environmental exposures in recent years, no consensus has emerged among experts yet. 
Unlike some previous efforts, the aim of this work is not assessing the strength of evidence for causal inference by considering all the relevant streams 
of research (Woodruff and Sutton, 2011), but to rate how certain one is that the ‘true’ estimate of the epidemiological association between an air 
pollutant and an adverse health effect lies within a particular range (Hultcrantz et al., 2017). Consistent with the standard GRADE framework, the 
certainty of the effect estimate is graded as high, moderate, low or very low. The ratings are subsequently used to select and underpin con-
centration − response functions in the process of deriving guideline exposure levels. 
The current approach was designed specifically to assess the certainty of the evidence from the systematic reviews commissioned by WHO to 
inform the update of global air quality guidelines (AQGs). Its development benefitted from previous experiences in applying GRADE in the field of 
occupational and environmental health, as well as specific expertise in air pollution epidemiology. The approach was extensively discussed in two 
Guideline Development Group meetings, pilot tested by the members of the Systematic Review Team and improved iteratively according to the 
feedback received. 
The Working Group accepted to start the rating of the certainty of the evidence for observational studies at moderate certainty evidence and not 
at high certainty, because of the risk of unmeasured confounding in observational studies. The certainty of the evidence from this level can then be 
downgraded or upgraded, based on the criteria per GRADE domain. The GRADE domains and the criteria considered when judging the certainty of 
the evidence are elaborated below. 
Reasons for downgrading 
Limitations in studies: Downgrade one or two levels 
For risk of bias in studies, there should be serious concern about bias in the studies that have the most weight in the meta-analysis to rate down 
the certainty of the total body of evidence with one level. If there are very serious concerns, the certainty can be downgraded with two levels. 
This is a judgement and there are no clear pre-set cut-off points (WHO, 2020). A judgement is based on the number of studies and the impact they 
have in the meta-analysis, as well as the seriousness of the risk of bias in these studies. One small study with very serious risk of bias but hardly an 
influence on the meta-analysis should not be a reason to downgrade, but two big studies with a considerable weight in the meta-analysis should. 
If the sensitivity analysis for risk of bias shows a considerable impact on the effect size, the conclusions could be based on the studies at low risk of 
bias only. In that case, there is no reason to downgrade because the body of evidence on which the conclusions are based is considered to be at low 
risk of bias only. 
Indirectness: Downgrade one or two levels 
The assessors should consider the extent to which the Population, Exposure, Comparator, Outcome(s), Study Design (PECOS) of the studies in the 
meta-analysis reflects the original PECOS question formulated at the beginning of the systematic review process (Guyatt et al., 2011). 
If there are considerable differences between the elements of the PECOS in the body of evidence compared to the original question, then the 
certainty of the body of evidence should be rated down with one level. This would, for example, be the case if the evidence consists of studies of 
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occupational exposure instead of exposure in the general population. 
Inconsistency: Downgrade one or two levels 
Inconsistency among studies means that there is a considerable difference in effect size between studies. For example, if there are studies in the 
body of evidence that show a harmful effect and also studies that show a preventive effect, this indicates serious inconsistency or heterogeneity. 
Usually there is more heterogeneity in observational than in experimental studies, because more factors can influence the effect size. Therefore, it 
is important to try to explain the heterogeneity. The first step should be to consider the factors that are listed for subgroup analyses in the protocol, as 
those that are most likely to be moderators of effect sizes. Another source of heterogeneity can be variation in risk of bias. This may explain part of 
the heterogeneity, and evaluation of only studies at low risk of bias should then decrease the heterogeneity. The difference in effect sizes between the 
subgroups should be tested for statistical significance. A rule of thumb to be used is to check if the confidence intervals of the subgroup pooled effect 
sizes do not overlap. 
Ideally, a meta-regression should be conducted including all moderators of the effect size, to find out how much heterogeneity remains after 
allowing for previously established reasons for heterogeneity. In practice, it is unlikely that all studies in a systematic review will have the necessary 
information to do a complete meta-regression including all previously documented reasons for heterogeneity. This could then be done on subsets of 
studies having the relevant information. 
Heterogeneity is often measured with the I2 statistic which varies between 0 and 100%, where 0% would indicate no heterogeneity and 100% 
large heterogeneity. Because the I2 statistic is a relative measure, it is difficult to make a judgement about the absolute amount of heterogeneity. As a 
result, the use of the prediction interval has been suggested (IntHout et al., 2016; Borenstein, 2019). 
The prediction interval provides an estimate of the distribution of the true effect sizes. To prevent overstating heterogeneity in observational 
studies, an 80% interval, and not the usual 95% interval, was chosen. For an 80% prediction interval, the true effect size for 80% of all populations 
would fall in this interval. This tells if the effect is consistent or if it varies substantially. It also tells if the effect is harmful in all populations, or if 
there is no effect in some populations or maybe even a preventive effect. 
To make a judgement about the amount of heterogeneity that cannot be explained and that would be a reason for concern and a reason for 
downgrading, the following approach is proposed. 
If the 80% prediction interval for a specific meta-analysis of relative risks is of the same size as the confidence interval, this indicates that there is 
no more variation in effect sizes than the statistical uncertainty. Then there is no reason for concern about heterogeneity. 
However, if the prediction interval is considerably wider than the confidence interval (e.g., double the size) and overlaps with 1, there is reason 
for concern about heterogeneity. The effect sizes of the studies vary so much that with different samples of studies the conclusions of the meta- 
analysis could be substantially different. For example, an alternative conclusion could be that there would be no risk. In this case, the certainty of the 
body of evidence would be downgraded with one level. 
Assessors need to provide a rationale for downgrading or not downgrading by explicitly addressing all of the issues mentioned above. This 
includes an assessment of how much of the heterogeneity can be explained. 
Imprecision: Downgrade one or two levels 
Precision of the pooled effect size is another domain to be judged for downgrading. If there are only a few participants and the confidence interval 
around the pooled effect size is wide, one is less inclined to believe that the results reflect the true effects. If there is considerable imprecision, there is 
a reason to downgrade. 
The cut-offs for downgrading because of imprecision given by the standard GRADE approach are applicable to clinical decision-making. Since in 
environmental health there are no clinical decision thresholds involved, only the second criterion of optimal information size can be applied to air 
pollution and health studies. 
Therefore, the proposed approach consists of calculating the number of participants needed for a single study that can measure the relative risk of 
interest with sufficient precision (Rothman and Greenland, 2018). If the number of participants in the meta-analysis is considerably lower than the 
number that would be needed for an adequately powered study, the certainty of the evidence is rated down. This is a relatively conservative 
approach, and implies that the information size of the meta-analysis would need to be larger than the single study because heterogeneity has to be 
taken into account. 
A method of calculating the sample size needed for a study with a specific relative risk and confidence interval was recently proposed by 
Rothman and Greenland (Ostro et al., 2010). As guidance, the calculation of the sample size needed to be able to assess a relative risk for mortality of 
1.05 per 10 μg/m3 increase of PM2.5 with a confidence interval with a width of 0.09 (1.01–1.10) is provided below. 
The event rate of mortality would be 0.0116 per person-year as in (Ostro et al., 2010); (Guyatt et al., 2011) . This would lead to a number of about 
940,000 person-years in the meta-analysis, containing sufficient information to assess the relative risk of interest with sufficient precision. 
The event rate in the example above was observed over a five-year follow-up period in a cohort of female public school teachers aged around 
54 years on average at baseline. As the confidence interval of the relative risk depends also and strongly on the event rate, the calculated number of 
about 940,000 person years should be viewed as indicative. It could be considerably smaller in older populations with higher event rates, and 
considerably larger in populations with lower event rates. 
Separate calculations are needed for short-term studies which do not deal with person years but with numbers of daily events. 
Publication bias: Downgrade one level 
Publication bias is assessed by a funnel plot and Egger’s test. If the funnel plot upon visual inspection shows that small studies with non-harmful 
effects are missing, this would be an indication of publication bias. This means that small (imprecise) studies that have a relative risk smaller than 1 
are missing. If there is no indication for these missing studies in the funnel plot, there is no use for the Egger’s test, because significance will result 
from other factors causing heterogeneity (Borenstein, 2019). The Egger’s test would just be used to confirm suspected publication bias detected from 
the funnel plot. 
It is important to note that the Egger’s test can easily produce statistical significance for other reasons than publication bias in case of hetero-
geneity. Members of the Working Group noted that the Egger’s test should not be used in case of heterogeneity, and that funnel plots should only 
include the studies included in the meta-analysis. Then, assessors should examine if small imprecise studies are missing in the funnel plots. 
Other approaches to assessing reporting bias, such as a subgroup analysis of multi-centre studies compared to single city studies in case of 
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evidence based on time series studies, an analysis of differences in effect estimates from earlier versus later studies, and a comparison to published 
results of attempts to quantify the magnitude of reporting bias, may help make a judgement. 
Reasons for upgrading 
The majority of the Working Group decided to recommend that upgrades for reasons of large effect size, all plausible confounding moving the 
relative risk estimate towards the null, and concentration − response gradient should be addressed independently from the results of applying the 
downgrading factors. Domains would be treated equally and independently, thus, leading to upgrading, downgrading or not changing the evidence 
level. A downgrade for any reason would not necessarily preclude upgrading for another reason. 
Large magnitude of effect size: Upgrade one level 
The standard GRADE approach proposes upgrading the certainty of the evidence in observational studies if the pooled effect size is large or very 
large, so that ‘the study design that is more prone to bias is unlikely to explain all of the apparent benefit or harm’. The cut-off point for a large effect 
size for harm is a relative risk > 2, while for a very large effect size is a relative risk > 5. These numbers are somehow arbitrary, and are not in the 
order of magnitude of the many relative risks reported in environmental health. 
Instead of taking a certain value of the relative risk as the cut-off point, it is reasonable to judge whether confounding could have easily 
influenced the pooled effect size found in the meta-analysis. To this end, the application of the E-value approach is helpful (VanderWeele and Ding, 
2017; Haneuse et al., 2019; Ioannidis et al., 2019; VanderWeele et al., 2019). This statistic is based on an assessment of how easily unmeasured 
confounders could explain away the relationship found between the exposure and the health outcome. It is based on the mathematical calculation of 
how large the effect of a confounder should be to explain away the relative risk that has been found in a study. With ‘explain away’, it is meant that 
such a confounder would reduce the relative risk that resulted from the observations in the study to 1. This effect (or E-value) is a function of the 
relative risk that has been found in a study or in a meta-analysis and is calculated as follows: E-value = RR + sqrt {RR * (RR – 1)}. The idea behind it 
is very similar to the ‘large effect’ concept in the standard GRADE framework but does not use absolute cut-offs for large effect sizes. 
The judgement is then to ascertain if an unmeasured confounder could easily have an association with the exposure and the outcome with 
relative risks as large as or larger than the E-value. It is important to note that this is always the covariate-adjusted association between the un-
measured confounder and the outcome, and also the covariate-adjusted association between the unmeasured confounder and exposure to air pol-
lution. If such a confounder could realistically have such strong relationships with both exposure and outcome, then unmeasured confounding could 
explain away the observed pooled relative risk. If one judges that it would be very unlikely that an unmeasured confounder would attain a relative 
risk as high as the E-value, then one can conclude that unmeasured confounding is unlikely to explain away the relative risk that has been observed. 
In that case, the certainty of the evidence can be upgraded because of a large effect size. 
It is important to note that a major part of the judgement is what a realistic value for the relative risk of the unmeasured confounder could 
possibly be. Preferably, this should be based on what is known about strong confounders for the association at hand. For the association air 
pollution– mortality, smoking would be an obvious choice about which much information is available concerning its relationship with all-cause and 
cause-specific mortality. However, the residual association between smoking and air pollution is highly variable across published studies, and 
calculations of E-values should report the covariate-adjusted associations with both air pollution and the outcome. The same logic applies to short- 
term studies where the covariate-adjusted associations between the confounder and the exposure (and the confounder–outcome) is relevant. 
All plausible confounding shifts the relative risk towards the null: Upgrade one level 
Another proposed reason for upgrading is if all plausible confounding would shift the relative risk towards the null and still there would be a 
significant relative risk. This requires considerable judgement of possible confounders. 
In most air quality and health studies, there would be a long list of possible confounders that would shift the relative risk in both directions. 
However, if one can reasonably argue that all confounding would have reduced the relative risk towards 1, then this will be a reason to upgrade the 
certainty of the evidence with one level. 
Concentration − response gradient: Upgrade one level 
The standard GRADE proposes upgrading the certainty of the evidence if there is a concentration − response relationship between exposure and 
adverse health outcomes. 
This domain is readily applicable to air quality and health studies. If there is an increase in risk with increasing exposure, either linearly or non- 
linearly, the certainty of the evidence would be upgraded with one level. 
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Table B1 
Health outcomes selected for the update of the AQGs in relation to long-term exposure to ambient air pollutants.      
Long-term exposure 
Pollutants Health outcome(s) used in 
latest WHO AQGs (2006) 
Health outcomes selectedfor 
updating WHO AQGs 
Justification for health outcome selection  
O3 No long-term guideline provided  • All-cause mortality  • Respiratory mortality 
CAUSALITY DETERMINATION  
• US EPA total mortality (suggestive, 2013)  • HC respiratory mortality (suggestive, 2013) 
SUPPORTING CONSIDERATIONS  
• Severity of health outcome, burden of disease  • Precautionary principle from expected increase of this pollutant due to climate change 
(policy implications and end-user perspectives). 
OTHER RELEVANT CAUSAL DETERMINATIONS(to be described in guidelines background 
chapter)  
• US EPA respiratory effects (likely, 2013)  • HC respiratory effects (suggestive, 2013) 
NO2 Respiratory effects in children  • All-cause mortality  • Respiratory mortality 
CAUSALITY DETERMINATION  
• US EPA (suggestive for total mortality, 2016)  • HC (suggestive for total mortality, 2016) 
SUPPORTING CONSIDERATIONS  
• Severity of health outcome, burden of disease  • Recent studies show associations with respiratory mortality, consistent with likely 
causality for respiratory effects (see other causal determinations below).  
• The causal determination of US EPA for mortality is suggestive, in light of the limited 
number of studies properly addressing confounding by other transport-related air 
pollutants.  
• The causal determination of US EPA of “likely causal” for respiratory effects (see other 
causal determinations below) takes into account respiratory mortality.  
• Also, studies on asthma incidence (mainly from USA) considered for respiratory effects 
are observed in children with specific genetic profiles, which may not be applying 
globally (differences in genetic makeup). 
OTHER RELEVANT CAUSAL DETERMINATIONS(to be described in guidelines background 
chapter)  
• US EPA respiratory effects (likely, 2016)  • HC respiratory effects (likely, 2016) 
HC: Health Canada science assessments, US EPA: United States Environmental Protection Agency Integrated Science Assessments (ISA), COHb: carboxyhaemoglobin, 
ED: Emergency Department visits; HA: Hospital Admissions, IHD: Ischaemic Heart Disease; COPD: chronic obstructive pulmonary disease ALRI: acute lower re-
spiratory infections; CV: cardiovascular admissions, IHD: Ischaemic Heart Disease; COPD: chronic obstructive pulmonary disease ALRI: acute lower respiratory 
infections; CV: cardiovascular  
Table B2 
Search strategy.     
MEDLINE (Search timeline: 1946–15.Jan.2018) 
#11 #8 and #9 and #10 448 
#10 #5 or #6 or #7 55,425 
#9 #3 or #4 1,068,043 
#8 #1 or #2 1,111,602 
#7 (“Nitrogen Dioxide” or NO2 or ozone or O3).tw. 27,723 
#6 (Nitrogen Dioxide or ozone).nm. 17,689 
#5 (Nitrogen Dioxide or ozone or air pollution).sh. 43,385 
#4 (cohort or Cox or hazard* or prospective).tw. 978,195 
#3 cohort studies.sh. 245,055 
#2 (mortality or death).tw. 1,092,011 
#1 (mortality or death).sh. 59,284 
EMBASE (1980–15.Jan.2018) 
#10 #7 and #8 and #9 823 
#9 #5 or #6 95,646 
#8 #3 or #4 2,020,425 
#7 #1 or #2 1,760,699 
#6 (“Nitrogen Dioxide” or NO2 or ozone or O3).tw. 44,586 
#5 (Nitrogen Dioxide or Ozone or air pollution).sh. 77,983 
#4 (cohort or Cox or hazard*).tw. 942,137 
#3 (cohort analysis or follow up).sh. 1,488,257 
#2 (mortality or death).tw. 1,508,949 
#1 (mortality or death).sh. 860,304 
Web of Science 1970–11.Jan.2018 
#4 #3 AND #2 AND #1 1,647 
#3 TS=(“nitrogen dioxide”) OR TS=(NO2) OR TS=(ozone) OR  
TS=(O3) OR TS=(“air pollution”) 
175,687 
#2 TS=(cohort) OR TS=(cox) OR TS=(hazard*) OR  
TS=(prospective) 
1,198,902 
#1 TOPIC: (mortality) OR TOPIC: (death) 1,398,001 
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Table B3 
Excluded studies (with reasons).    
No quantitative HR provided 
1. Peng Z, Liu C, Xu B, Kan H, Wang W. Long-term exposure to ambient air pollution and mortality in a Chinese tuberculosis cohort. Science of the Total Environment. 
2017;580:1483–8. 
2. Lin JH, Yen TH, Weng CH, Huang WH. Environmental NO2 level is associated with 2-year mortality in patients undergoing peritoneal dialysis. Medicine (United States). 
2015;94(1):e368. 
3. Andersen ZJ, de Nazelle A, Mendez MA, Garcia-Aymerich J, Hertel O, Tjonneland A, et al. A study of the combined effects of physical activity and air pollution on mortality 
in elderly urban residents: The Danish Diet, Cancer, and Health Cohort. Environmental Health Perspectives. 2015;123(6):557–63. 
4. Villeneuve PJ, Jerrett M, Su J, Burnett RT, Chen H, Brook J, et al. A cohort study of intra-urban variations in volatile organic compounds and mortality, Toronto, Canada. 
Environmental Pollution. 2013;183:30–9. 
5. Vedal S, Campen MJ, McDonald JD, Larson TV, Sampson PD, Sheppard L, et al. National Particle Component Toxicity (NPACT) initiative report on cardiovascular effects. 
Research report (Health Effects Institute). 2013(178):5–8. 
6. Gan WQ, Davies HW, Koehoorn M, Brauer M. Association of long-term exposure to community noise and traffic-related air pollution with coronary heart disease mortality. 
American Journal of Epidemiology. 2012;175(9):898–906. 
7. Nawrot TS, Vos R, Jacobs L, Verleden SE, Wauters S, Mertens V, et al. The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung 
transplantation. Thorax. 2011;66(9):748–54. 
8. Krewski D, Burnett RT, Goldberg M, Hoover K, Siemiatycki J, Abrahamowicz M, et al. Reanalysis of the Harvard Six Cities Study, Part II: Sensitivity analysis. Inhalation 
Toxicology. 2005;17(7–8):343–53. 
9. Pope CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. Jama- 
Journal of the American Medical Association. 2002;287(9):1132–41. 
10. Lipfert FW, Perry Jr HM, Miller JP, Baty JD, Wyzga RE, Carmody SE. The Washington University-EPRI Veterans' Cohort Mortality Study: preliminary results. Inhalation 
toxicology. 2000;12 Suppl 4:41–73. 
11. Abbey DE, Lebowitz MD, Mills PK, Petersen FF, Beeson WL, Burchette RJ. LONG-TERM AMBIENT CONCENTRATIONS OF PARTICULATES AND OXIDANTS AND 
DEVELOPMENT OF CHRONIC DISEASE IN A COHORT OF NONSMOKING CALIFORNIA RESIDENTS. Inhalation Toxicology. 1995;7(1):19–34. 
12. Dockery DW, Pope ICA, Xu X, Spengler JD, Ware JH, Fay ME, et al. An association between air pollution and mortality in six U.S. cities. New England Journal of Medicine. 
1993;329(24):1753–9. 
13. Abbey DE, Colome SD, Mills PK, Burchette R, Beeson WL, Tian Y. Chronic disease associated with long-term concentrations of nitrogen dioxide. Journal of exposure analysis 
and environmental epidemiology. 1993;3(2):181–202. 
Results replicated elsewhere 
1. Beelen R, Hoek G, Raaschou-Nielsen O, Stafoggia M, Andersen ZJ, Weinmayr G, et al. Natural-cause mortality and long-term exposure to particle components: An Analysis 
of 19 European cohorts within the multi-center ESCAPE project. Environmental Health Perspectives. 2015;123(6):525–33. 
2. Wang M, Beelen R, Stafoggia M, Raaschou-Nielsen O, Andersen ZJ, Hoffmann B, et al. Long-term exposure to elemental constituents of particulate matter and cardiovascular 
mortality in 19 European cohorts: Results from the ESCAPE and TRANSPHORM projects. Environment International. 2014;66:97–106. 
3. Gan WQ, Tamburic L, Davies HW, Demers PA, Koehoorn M, Brauer M. Changes in residential proximity to road traffic and the risk of death from coronary heart disease. 
Epidemiology. 2010;21(5):642–9. 
4. Beelen R, Hoek G, van den Brandt PA, Goldbohm RA, Fischer P, Schouten LJ, et al. Long-term effects of traffic-related air pollution on mortality in a Dutch cohort (NLCS-AIR 
study). Environmental Health Perspectives. 2008;116(2):196–202. 
5. Krewski D, Burnett R, Jerrett M, Pope CA, Rainham D, Calle E, et al. Mortality and long-term exposure to ambient air pollution: ongoing analyses based on the American 
Cancer Society cohort. Journal of toxicology and environmental health. 2005;Part A. 68(13–14):1093–109. 
6. Jerrett M, Burnett RT, Ma RJ, Pope CA, Krewski D, Newbold KB, et al. Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology. 2005;16(6):727–36. 
7. Krewski D, Burnett RT, Goldberg MS, Hoover BK, Siemiatycki J, Jerrett M, et al. Overview of the Reanalysis of the Harvard Six Cities Study and American Cancer Society 
study of particulate air pollution and mortality. Journal of Toxicology and Environmental Health - Part A. 2003;66(16–19):1507–51. 
HR for NOX not NO2 
1. Cohen G, Levy I, Yuval, Kark JD, Levin N, Broday DM, et al. Long-term exposure to traffic-related air pollution and cancer among survivors of myocardial infarction: A 20- 
year follow-up study. European Journal of Preventive Cardiology. 2017;24(1):92–102. 
2. Stockfelt L, Andersson EM, Molnar P, Rosengren A, Wilhelmsen L, Sallsten G, et al. Long term effects of residential NOx exposure on total and cause-specific mortality and 
incidence of myocardial infarction in a Swedish cohort. Environmental Research. 2015;142:197–206. 
3. Cao J, Yang C, Li J, Chen R, Chen B, Gu D, et al. Association between long-term exposure to outdoor air pollution and mortality in China: A cohort study. Journal of 
Hazardous Materials. 2011;186(2–3):1594–600. 
4. Lipfert FW, Wyzga RE, Baty JD, Miller JP. Air pollution and survival within the Washington University-EPRI veterans cohort: Risks based on modeled estimates of ambient 
levels of hazardous and criteria air pollutants. Journal of the Air and Waste Management Association. 2009;59(4):473–89. 
5. Nafstad P, Haheim LL, Wisloff T, Gram F, Oftedal B, Holme I, et al. Urban air pollution and mortality in a cohort of Norwegian men. Environmental Health Perspectives. 
2004;112(5):610–5. 
Other causes of death 
1. Cappellari M, Turcato G, Zannoni M, Forlivesi S, Maccagnani A, Bonora A, et al. Association between short- and medium-term air pollution exposure and risk of mortality 
after intravenous thrombolysis for stroke. Journal of Thrombosis and Thrombolysis. 2017:1–7. 
2. Tseng E, Ho WC, Lin MH, Cheng TJ, Chen PC, Lin HH. Chronic exposure to particulate matter and risk of cardiovascular mortality: cohort study from Taiwan. BMC public 
health. 2015;15:936. 
3. Sorensen M, Luhdorf P, Ketzel M, Andersen ZJ, Tjonneland A, Overvad K, et al. Combined effects of road traffic noise and ambient air pollution in relation to risk for stroke? 
Environmental Research. 2014;133:49–55. 
4. Bhinder S, Chen H, Sato M, Copes R, Evans GJ, Chow CW, et al. Air pollution and the development of posttransplant chronic lung allograft dysfunction. American Journal of 
Transplantation. 2014;14(12):2749–57. 
5. Beelen R, Stafoggia M, Raaschou-Nielsen O, Andersen ZJ, Xun WW, Katsouyanni K, et al. Long-term Exposure to Air Pollution and Cardiovascular Mortality An Analysis of 
22 European Cohorts. Epidemiology. 2014;25(3):368–78. 
6. Raaschou-Nielsen O, Sorensen M, Ketzel M, Hertel O, Loft S, Tjonneland A, et al. Long-term exposure to traffic-related air pollution and diabetes-associated mortality: a 
cohort study. Diabetologia. 2013;56(1):36–46. 
7. Chen H, Goldberg MS, Burnett RT, Jerrett M, Wheeler AJ, Villeneuve PJ. Long-term exposure to traffic-related air pollution and cardiovascular mortality. Epidemiology. 
2013;24(1):35–43. 
8. Zanobetti A, O'Neill MS, Gronlund CJ, Schwartz JD. Summer temperature variability and long-term survival among elderly people with chronic disease. Proceedings of the 
National Academy of Sciences of the United States of America. 2012;109(17):6608–13. 
9. Andersen ZJ, Kristiansen LC, Andersen KK, Olsen TS, Hvidberg M, Jensen SS, et al. Stroke and long-term exposure to outdoor air pollution from nitrogen dioxide: A cohort 
study. Stroke. 2012;43(2):320–5. 
10. Zhang PF, Dong GH, Sun BJ, Zhang LW, Chen X, Ma NN, et al. Long-Term Exposure to Ambient Air Pollution and Mortality Due to Cardiovascular Disease and 
Cerebrovascular Disease in Shenyang, China. Plos One. 2011;6(6). 
11. Zanobetti A, Schwartz J. Ozone and survival in four cohorts with potentially predisposing diseases. American Journal of Respiratory and Critical Care Medicine. 
2011;184(7):836–41. 
12. Spencer-Hwang R, Knutsen SF, Soret S, Ghamsary M, Beeson WL, Oda K, et al. Ambient air pollutants and risk of fatal coronary heart disease among kidney transplant 
recipients. American Journal of Kidney Diseases. 2011;58(4):608–16. 
(continued on next page) 
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Table B3 (continued)   
13. Gan WQ, Koehoorn M, Davies HW, Demers PA, Tamburic L, Brauer M. Long-term exposure to traffic-related air pollution and the risk of coronary heart disease 
hospitalization and mortality. Environmental Health Perspectives. 2011;119(4):501–7. 
14. McKean-Cowdin R, Calle EE, Peters JM, Henley J, Hannan L, Thurston GD, et al. Ambient air pollution and brain cancer mortality. Cancer Causes & Control. 
2009;20(9):1645–51. 
15. Beelen R, Hoek G, Houthuijs D, Van Den Brandt PA, Goldbohm RA, Fischer P, et al. The joint association of air pollution and noise from road traffic with cardiovascular 
mortality in a cohort study. Occupational and Environmental Medicine. 2009;66(4):243–50. 
16. Schikowski T, Sugiri D, Ranft U, Gehring U, Heinrich J, Wichmann HE, et al. Does respiratory health contribute to the effects of long-term air pollution exposure on 
cardiovascular mortality? Respiratory research. 2007;8:20. 
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Table B4 
New studies published after last search.          
Exposure Study Country Cohort Study population Follow up period Outcome HR (95%CI)  
NO2 Hanigan 2019 Australia 45 and Up General population 2007–2015 All cause 1.03 (0.98, 1.07) 
Hvidtfeldt 2019 Denmark Danish Diet, Cancer and Health General population 1993–2015 All cause 1.05 (1.01, 1.09) 
Respiratory 1.03 (0.97, 1.09) 
Klompmaker 2020 Netherlands Dutch National Health Survey General population 2013–2017 All cause 0.99 (0.97, 1.01) 
Respiratory 0.98 (0.91, 1.06) 
Lim 2019 US NIH-AARP General population 1995–2011 All cause 1.04 (1.02, 1.05) 
Respiratory 1.04 (0.99, 1.08) 
COPD 1.03 (0.98, 1.08) 
ALRI 1.22 (1.11, 1.35) 
O3(Annual) Hvidtfeldt 2019 Denmark Danish Diet, Cancer and Health General population 1993–2015 All cause 0.95 (0.91, 1.00) 
Respiratory 0.97 (0.89, 1.05) 
Lim 2019 US NIH-AARP General population 1995–2011 All cause 0.99 (0.98, 1.00) 
Respiratory 1.04 (1.00, 1.09) 
COPD 1.09 (1.03, 1.15) 
ALRI 1.00 (0.90, 1.11) 
O3(Warm season) Lim 2019 US NIH-AARP General population 1995–2011 All cause 1.00 (0.99, 1.01) 
Respiratory 1.04 (1.02, 1.06) 
COPD 1.05 (1.02, 1.08) 
ALRI 1.05 (0.99, 1.10) 
Kazemiparkouhi 2019 US Medicare beneficiaries General population 2000–2008 All cause 1.013 (1.012, 1.014) 
Respiratory 1.036 (1.032, 1.039) 
COPD 1.065 (1.060, 1.069)    
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Figs. B1–B13. 
Fig. B1. NO2 and all-cause mortality – funnel plot.  
Fig. B2. NO2 and all-cause mortality – stratification by patient and population groups.  
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Fig. B3. NO2 and all-cause mortality – stratification by individual vs area-level confounder control.  
Fig. B4. NO2 and all-cause mortality – stratification by WHO region.  
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Fig. B5. NO2 and all-cause mortality – stratification by risk of bias for confounding domain.  
Fig. B6. NO2 and respiratory mortality – funnel plot.  
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Fig. B7. NO2 and respiratory mortality, stratification by confounder control.  
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Fig. B8. NO2 and respiratory mortality, stratification by WHO region.  
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Fig. B10. NO2 and respiratory mortality – multi-pollutant models.  
Fig. B9. NO2 and all-cause mortality – multi-pollutant models.  
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Fig. B11. NO2 and COPD & ALRI mortality – multi-pollutant models.  
Fig. B12. O3 annual exposure and mortality – multi-pollutant models.  
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Appendix C. Supplementary material 
Supplementary data to this article can be found online at https://doi.org/10.1016/j.envint.2020.105998.  
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